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1 
INTRODUCTION 
During the last ten years, adriamycin (%) and daunomycin 
(2) have become major components in the arsenal of chemo-
therapeutic agents for the treatment of a wide range of 
cancers. The less toxic 11-deoxyanthracyclines have recently 
been discovered and may prove to be even more effective anti­
cancer drugs than adriamycin and daunomycin. Aclacinomycin 
A (3) is the most promising member of this new group of 
anthracyclines. This manuscript will detail the results of 
a program to develop a total synthesis of the aglycone of 
aclacinomycin A and a total synthesis of a structurally 
related compound, ekatetrone (_5). 
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HISTORICAL 
The search for effective chemical agents for the treat­
ment of a wide range of cancers has led investigators to 
study the antitumor properties of a variety of naturally 
occurring compounds. This search has resulted in the 
discovery of several very effective classes of naturally 
occurring antitumor compounds. The anthracycline antitumor 
antibiotics are among the most active compounds discovered 
in the last ten years. Adriamycin ^  and daunomycin also 
known as daunorubicin, have proven to be very effective and 
are widely used clinically. Efforts to develop even more 
active antitumor agents with fewer side effects led to the 
discovery of other anthracyclines, among which aclacinomycin 
A ^  appears to be of special interest. Aclacinomycin A, 
when compared to adriamycin and daunomycin, has equally high 
antitumor activity and reduced toxic side effects. The 
lower cardiotoxicity of aclacinomycin A is especially impor­
tant. 
OH 
3 
CH, 
COUCH 
OH 0 
6 N(CH3)2 
Group I 
0 OH 0 
OH 
OH 
R2 R3 
Daunomycin CH3 H daunosamine 
Adriamycin CH3 OH daunosamine 
Carminomycin H H daunosamine 
11-Deoxydaunomycin 
11-Deoxyadriamycin 
CH.O 
OH 
daunosamine 
daunosamine 
CHnO 
ll-Deoxy-13-dihydrodaunomycin 
ll-Deoxy-13-deoxydaunomycin 
Group II 
^1 
OH 
H 
CO^CH^ 
Aklavinone 
Aklavin 
Aclacinomycin A 
Aclacinomycin B 
Aclacinomycin Y 
R2 
daunosamine 
daunosamine 
R 
H 
Rhodosamine 
Rhodosamine + 2-Deoxy-L-fucose + L-
Cinerulose 
Rhodosamine + 2-Deoxy-L-fucose + 
Cinerulose B 
Rhodosamine + 2-Deoxy-L-fucose + 
Amicetose 
5 
Group III 
Group IV 
Group V 
''//OH 
OH 0 OH 
Citromycins 
OH R 
OH 0 
Rhodomycins 
OH 0 
R^ = H or OH 
Rg = COgCHg or OH 
Pyrromycin COgCHg 
R2 
H 
R3 
Rhodosamine 
Cinerubin A COgCHg H Rhodosamine + 2-
Deoxy-L-fucose + 
L-Cinerulose 
Cinerubin B C02CH3 H Rhodosamine + 2-
Deoxy-L-fucose + 
Cinerulose B 
Marcellomycin COgCHg H Rhodosamine 4- 2-
Deoxy-L-fucose + 
2-Deoxy-L-fucose 
Collinemycin H COgCHg Rhodosamine + 2-
Deoxy-L-fucose 
Mimimycin H COgCHg Rhodosamine + 2-
Deoxy-L-fucose + 
2-Deoxy-L-fucose 
6 
R, 
Rudolphomycin 
Alc indoromyc in 
10-Descarbomethoxy 
Marcellomycin 
10-Descarb ornethoxy 
Rudolphomycin 
Rhodorubin A 
Rhodorubin B 
Rhodorubin G 
COgCHg H 
COgCHg H 
H 
H 
H 
H 
COgCHg H 
COgCHg H 
COgCHg H 
Rhodosamine + 2-
Deoxy-L-fucose + 
Rednose 
Monodemethylrhodos-
amine + 2-Deoxy-
L-fucose + 2-
Deoxy-L-fucose 
Rhodosamine +  2 -
Deoxy-L-fucose + 
2-Deoxy-L-fucose 
Rhodosamine + 2-
Deoxy-L-fucose + 
Rednose 
Rhodosamine + 2-
Deoxy-L-fucose + 
Rhodinose 
Rhodosamine + 2-
Deoxy-L-fucose + 
D-Cinerulose 
Rhodosamine + 2-
Deoxy-L-fucose + 
Amicetose 
Group VI 
Nogalamycin 
Nogamycin 
7-Con-O-Methylnogarol 
COgCHg 
H 
H 
Nogalose 
Nogalose 
CHo 
7 
Group VII 
CH.O 
Steffimycin 
Steffimycin B 
2-0-Methy1-L-rhamnose 
2,4-Di-0-methy1-L-rhamnose 
Some sugars found in anthracyclines; 
OH OH 
Amicetose 
OH 
Rhodinose 2-Deoxy-L-fucose 
NHCH 
Monodemethylrhodos- Daunosamine 
amine 
OH 
CH 
H 
OH N(CHg)2 
Rhodosamine 
OH OH 
CH 
HQ 
1 OH H 
2-0-Methyl-L-
rEamnose 
OCH, 
L-Cinerulose D-Cinerulose 
8 
OH OH OH 
0 
Cinerulose-B 
CF 
OH HC 
2,4-Di-O-methyl-L-
rhamnose 
3 
Nogalose 
CH3-7\ OH 
0 
Rednose NH 2 
Several dozen naturally occurring anthracyclines have 
been isolated and many synthetic analogues have been 
developed. The biochemical and medical aspects of these 
compounds have been covered in several excellent reviews 
(1-6). The most important aspects of structure and activity 
relationships between the different anthracyclines will be 
summarized here and, along with more recent information, the 
increasing importance of the 11-deoxy anthracyclines related 
to aclacinomycin will be shown. 
The anthracyclines can be divided into seven groups 
based on the substitution pattern found on the aglycone 
portion of the molecule. Historically, compounds in Group 
IV having the rhodomycinone aglycone were.the first to be 
isolated and have their structures determined (7). The 
rhodomycins were found to be highly toxic compounds (7). 
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Cinerubin A and cinerubin B were first isolated in 1959. 
They were found to be cytotoxic and have antibacterial and 
antitumor properties, but were also found to be highly 
toxic in mice and rats (8). 
Daunomycin, the first clinically effective anthracycline, 
was discovered in 1963 (9a). While for most uses it proved 
to be highly toxic, daunomycin was especially effective 
for treatment of acute leukemias (9b). 
The structure of adriamycin was determined in 1969 
(10a) and soon afterward it was shown to be less toxic than 
daunomycin and active against a broader spectrum of tumors 
(10b). Adriamycin is effective against breast cancer, 
osteogenic sarcoma, cancers of the bladder, lung, thyroid 
and ovary, Wilms' tumor, neuroblastoma, Hodgkin's disease 
and other lymphomas and acute leukemias. Many solid tumors 
which respond to adriamycin treatment are often unresponsive 
to other chemotherapy (1).• 
Adriamycin and daunomycin were isolated from a mutant 
strain of Streptomyces peucetius. Because of their wide 
range of anticancer activity, especially the effectiveness 
of adriamycin against solid tumors, a study of other 
Streptomyces strains has led to the discovery of dozens of 
new anthracyclines. 
Workers at Bristol Laboratories isolated a series of 
anthracyclines based on pyrromycinone (Group V) from the 
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Bohemic acid complex (11), It is the practice at Bristol 
to name antitumor antibiotic complexes after operas. 
Compounds isolated from the complex are given names based 
on characters in the libretto. A number of compounds based 
on nogalomycinone (12) (Group VI) and steffimycinone (13) 
(Group VII) were isolated by other workers. Very recently 
Arcamore and coworkers isolated compounds in the 11-deoxy 
adriamycin and 11-deoxydaunomycin series (14). 
Probably the most important discovery came in 1975, 
when the aclacinomycins (Group II) were isolated and their 
structures determined (15). Aclacinomycins A and B were 
isolated from Streptomyces galileus MA144-M1. Aclacinomycin 
A was found to be highly active against L1210 and P388 
leukemia, Ehrich ascites tumor, rat hepatomas, S-180 solid 
tumor, CD mammary carcinoma, colon 38 carcinoma and 
moderately or weakly active against several other cancers 
(4). It was found to be ten times less cardiotoxic than 
adriamycin in hamsters and rabbits (16). 
The structure of aclacinomycin A was determined by mild 
acid hydrolysis to give aklavinone, a naturally occurring 
substance whose structure had previously been determined 
(17), and three sugars. The sugars were identified by TLC 
(thin layer chromatography) comparison with the known sugars 
in cinerubin A. 
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The anthracyclines containing a two carbon side chain 
at C-9 are thought to arise biosynthetically from the 
combination of one propionate and nine acetate units, giving 
a polyketide intermediate which is common to all of the 
compounds (18). The anthracyclines with a one carbon side 
chain at C-9 must arise from the combination of ten acetate 
units. Labelling studies and use of mutated strains of 
Streptomyces indicate that aklavinone 4 is a common inter­
mediate in the biosynthesis of the other anthracyclines (5). 
For example, by various oxidations and decarbalkoxylation, 
daunomycinone can be obtained from aklavinone. 
The metabolism of aclacinomycin A has been studied 
using rat liver homogenates (4). Under aerobic conditions, 
the ketone of the cinerulose sugar becomes reduced. Under 
anaerobic conditions, reductive cleavage of the glycosidic 
linkage takes place. The dimeric reduction product has 
also been isolated from the fermentation broth of Streptomyces 
galileus (19). Some of the metabolic products or 
.0 0 OH (5h 
4 
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derivatives of them have been isolated during animal test­
ing with aclacinomycin A (4). 
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The mechanism of action of the anthracyclines has been 
studied in great detail. The antitumor activity is thought 
to arise mainly from a binding interaction between the 
anthracycline and DNA (deoxyribonucleic acid). This 
provides a unique circumstance. Due to the very detailed 
knowledge of the structure of DNA as a biological receptor, 
a very good model for DNA-anthracycline binding can be 
proposed. 
When isolated double stranded DNA and an anthracycline 
are mixed in solution, very obvious changes occur in the 
physical and spectral properties of both compounds (20). 
This information, in combination with data from X-ray 
diffraction studies (21) of the DNA-anthracycline complex, 
clearly indicates that the anthracycline intercalates 
between the base pairs of the DNA helix. 
The X-ray structure determination of daunomycin and 
NMR analyses (22) show that the A ring exists in a half 
chair conformation. This completes the information needed 
to propose a detailed model of the binding interaction. 
Extensive overlap between the planar tricyclic chromophore 
of the anthracycline and the DNA base pairs lying immediate­
ly above and below it is the major binding forcé. This 
interaction is further stabilized by a variety of ionic 
and hydrogen bonding interactions (1). The amino sugar 
appears to lie in the major groove of the DNA helix, with 
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its protonated amino group interacting in an ionic bond with 
the second phosphate from the intercalation site. Hydrogen 
bonding between the C-9 hydroxyl and the first phosphate 
from the site is also possible. Alternatively, an intra­
molecular C-7 oxygen to C-9 hydroxyl hydrogen bond may 
exist. In the case of adriamycin, the C-14 hydroxyl may also 
participate in hydrogen bonding. 
Anthracycline A-Ring Conformation 
It is thought that the intercalation and binding prevent 
conformational changes in the DNA helix which are necessary 
to initiate nucleic acid synthesis, thus causing the death 
of the cancer cell. However, intercalation can not account 
for the DNA strand breaks observed vivo with anthracycline 
use (23) . Recent evidence indicates that the enzyme NADPH 
cytochrome P-450 reductase, which is present in the microsomes 
of tumor cells, is capable of catalyzing the single electron 
reduction of quinone antibiotics (23), In the presence of 
molecular oxygen this leads to the formation of superoxide 
radicals, which then would do the actual damage to the DNA 
strand leading to inhibition of nucleic acid synthesis and 
15 
cell death. The tight binding of anthracyclines to DNA 
would allow formation of superoxide radicals in close proxim­
ity to their site of action. 
Having a fairly good idea of how anthracyclines produce 
their effect on cancer cells is very useful in rationalizing 
differences in activity among the different groups of 
anthracyclines. Some of the most important structure 
activity relationships will be outlined and, where possible, 
related to the proposed model for anthracycline binding 
to DNA. 
Aclacinomycin A and 1-deoxypyrromycin are non-mutagenic 
in the Ames Salmonella test (24) . Daunomycin and adriamycin 
are highly mutagenic, while N-methyl daunomycin is weakly 
mutagenic and N-dimethyl daunomycin is non-mutagenic. N-
demethyl pyrromycin and N-demethyl aclacinomycin are muta­
genic. Aklavinone and daunomycinone are non-mutagenic. This 
^ Flavoprotein 
(oxidized) NADPH 
0 
NADP y Flavoprotein / (reduced) 
0 
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means that the nature of the amino moiety of the anthra-
cycline glycosides determines mutagenicity. Whether or not 
the nitrogen is methylated must influence the amino group's 
interaction with the DNA helix and thus, influence whether the 
compound is mutagenic. 
Comparisons of compounds in the aklavinone and pyrro-
mycin series, in which the only structural difference is 
the presence or absence of the C-1 hydroxyl group, show that 
activity, as measured by median survival time of treated 
versus control animals, is best for the aklavinone series 
(4). Therefore, compounds not having a C-1 hydroxyl may be 
better candidates for clinical testing. 
Studies involving nogalamycin and C-10 decarbomethoxy 
nogalamycin indicate that the presence of the ester gives 
the compound increased potency (25). The potency of 
marcellomycin and rudolphomycin also decreases when the 
carbomethoxy group is removed. The C-10 epimers of marcello­
mycin and rudolphomycin have much reduced potency and 
slightly reduced activity (4). This structural change would 
be expected to alter the conformation of the A ring, lead­
ing to changes in drug binding characteristics with DNA. 
The composition of the saccharide chain also affects 
the activity of the anthracyclines. Removal of the methyl 
groups from the 3'-amino group of rhodosamine greatly 
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decreases potency, while replacement of rhodosamine by 2-
deoxy-L-fucose in aclacinomycin causes complete loss of 
activity (4). 
The length of the saccharide chain plays an important 
role in determining activity (26). The anthracyclines can 
be divided into two groups based on their effect on DNA 
and RNA (ribonucleic acid) synthesis. The first group 
consists of adriamycin, carminomycin and pyrromycin. These 
compounds inhibit DNA and whole cell RNA synthesis at 
nearly equivalent concentrations. The concentrations for 
inhibiting DNA and nucleolar RNA synthesis are also simi­
lar. In the second group, consisting of marcellomycin, 
mussetamycin and aclacinomycin A, whole cell RNA synthesis 
is inhibited at six to seven times lower concentrations 
than for DNA inhibition. Nucleolar RNA synthesis is 
inhibited at from 170 to 1256 times lower concentrations 
than for DNA. Because similar aglycones are common to both 
groups, the difference in the saccharide chain length must 
cause the difference in activity. It has been suggested that 
the selective effect on nucleolar RNA synthesis by compounds 
containing a trisaccharide is due to the long trisaccharide 
chain occupying the major or minor groove of the DNA helix 
and interfering with the movement of RNA polymerase along 
the helix (27). 
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Many of the comparisons made between the aclacinomycin 
and adriamycin group compounds point to possible advantages 
to the use of aclacinomycin A. This prompted human clini­
cal trials of aclacinomycin A to be initiated in Japan in 
the late 1970's. Preliminary results indicate several 
advantages to the use of aclacinomycin A (28). A number 
of side effects are associated with the use of adriamycin, 
including myelosuppression, stomatitis, alopecia and 
myocardiopathy (1). Most of these effects are only 
temporary or can be easily treated, but the cardiotoxicity 
is a serious problem. It takes the form of temporary EKG 
changes and irreversible dose-related deterioration of the 
heart muscle, which is a potential cause of conjestive heart 
failure. If total cumulative doses are kept below 550 mg/m 
(29), the cardiotoxicity is not a major problem. No good 
mechanism has been suggested for anthracycline cardiotoxicity. 
Adriamycin is known to cause degeneration of mitochondria 
in cardiac cells and this may play an important role in the 
toxicity (30). Clinical evidence to date gives no indication 
of permanent heart damage related to aclacinomycin A use, 
and the other toxic side effects appear to be milder or 
less frequent than when adriamycin is used (28). Another 
important advantage of aclacinomycin is that it is active 
when given orally, while adriamycin and daunomycin are not 
(4). 
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It has been found recently that combinations of anti­
cancer drugs often work better than the administration of 
one drug alone. For example, adriamycin is often given 
in combination with vincristine, allowing the same anti­
tumor effect to be realized from a smaller dose of the 
toxic anthracycline. Studies in animal systems using P338 
leukemia show that aclacinomycin, in combination with cyclo­
phosphamide or vincristine, causes a synergistic 
therapeutic effect in producing significant lengthening 
of life span, while none of the drugs alone produced the 
same effect (31) . 
One last example of another recently discovered compound 
is ekatetrone While ekatetrone is not formally considered 
an anthracycline, it has many structural features in 
common with the 11-deoxyanthracyclines. 
0 
CNHg 
II ^ 
0 
0 
5 
Ekatetrone was isolated from a strain of Streptomyces 
aureofaciens and its structure was determined by chemical 
and spectral means (32). It has no antibacterial activity. 
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but ^  vivo testing showed that it inhibits the growth of 
Ehrlich ascites carcinoma (32). No comparisons of activity 
with any anthracyclines have been reported. 
Ekatetrone is thought to arise biosynthetically from 
protetrone a known metabolite of Streptomyces aureofaciens 
(5). A biosynthetic relationship has also been proposed 
between protetrone and the tetracyclines (33). 
0 0 
OH OH 
CNH 
0 
OH OH 
CNH 
reductase 
» 
.OH 
OH OH 
CNH 
reductase 
0 
Because of the clinical importance of adriamycin and 
daunomycin and the need to find analogues with fewer side 
effects, a great deal of research has been done by synthetic 
chemists to find efficient methods of making these compounds, 
especially the aglycone portion of the molecule. Methods 
published through early 1979 have been reviewed (34). More 
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recent methods are referenced in a paper by Kelly and 
coworkers (35). 
As investigators have become aware of the possible 
advantages of clinical use of aclacinomycin A, methods have 
been developed for the synthesis of 11-deoxyanthracyclines. 
Jung and Lowe (36) hoped to use a Diels-Alder approach for 
synthesizing aklavinone and pyrromycinone. Model studies 
showed that the pyrone 2 reacted in a regiospecific manner 
with juglone ^  to give, after oxidation and demethylation, 
chrysophanol ^  in 62% overall yield. None of the other 
0 
OCHr 
z ' 
regioisomer was isolated. The pyrone also reacted with 
napthazarin ^  in a similar manner to give helminthosporin 
JLl in 38% overall yield. Jung planned to use the reaction 
of bicyclic pyrone 12 to build up the tetracyclic skeleton. 
OH 0 
+ 
T OCH3 
10 
22 
X 0 X 0 
OH 0 
X = H or OH 
0 
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No further progress has been reported on this route 
since the initial report in early 1978. Pyrone ^  may not 
have been obtainable. I'Jhile Jung and Lowe had a nice solu­
tion to the problem of regiospecific introduction of the 
oxygenated functionality, even if the desired tetracyclic 
compound had been obtained, there may have been formidable 
problems associated with further regiospecific functionali-
zation of the A ring. 
Jung and Lowe's work points out the importance of 
developing regiocontrolled methods for generating the DCB 
rings. The 11-deoxyanthracyclines lack the symmetry in 
rings C and B found in the adriamycin series, which some­
what simplifies the synthesis of adriamycin. 
Very recently another regiospecific Diels-Alder 
approach has been published (37) . Diels-Alder reaction of 
diene ^  with various quinones at room temperature gave 
several tetracyclic compounds. Addition to juglonejB is 
regiospecific and formation of compound ^  constitutes a 
formal synthesis of recently isolated 11-deoxydaunomycinone. 
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SbFj/HF 
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OH 0 
+ 13 
)H 0 OH 
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SbFc/HF 
15b 2 ^ 
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3 SbFg/HF 
CH3O 0 OEt 
91% 
CHoO 0 OH 
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Further elaboration of the A ring from this type of ketone 
has been accomplished in the adriamycinone and daunomycinone 
series (38). 
The reaction product of diene 1^ with juglone methyl 
ether ^  has the opposite regiochemistry of the product 
with juglone. The known regiochemistry of addition of vinyl 
ketene acetals to haloquinones (39) was also observed with 
quinone ^  and diene ^ . This method provides an extremely 
efficient route to 11-deoxydaunomycin and 11-deoxyadriamycin. 
CH3O 0 
Ô0*" 
0 0 OH 
36% overall yield 
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CH.O 
+ U 
55% overall yield 
The use of carbanion chemistry has provided another 
method for synthesizing anthracyclines. Parker and Kallmerten 
(40) and Kende and coworkers (41) have independently reported 
the use of the anion of substituted benzyl nitriles to 
generate the daunomycinone skeleton 
0CH3 
CH30 
COGE 
0CH3 
OCHo CN 
0 NaH/THF 
OCHo 0 
CH3O OCH3 
COgEt 
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19 
CH3O OCH3 0 
At the most recent American Chemical Society meeting, 
extensions of this work to the 11-deoxyanthracyclines were 
reported (42). In a model system, Parker and Kallmerten 
hydrolyzed the Michael adduct ^  to the acid and then 
subjected the acid to Birch reduction conditions, causing 
decyanation to ^ . After Friedel-Crafts ring closure, 
oxidation and acetylation, a model 23 for the BC rings of 
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11-deoxyanthracyclines was obtained. This should provide 
a completely regiospecific route to 11-deoxydaunomycinone. 
OCH3 ÇN O.CH 
OCH, 
COgEt 
21 
CO«H 
In the last few years, several other annelation methods 
based on carbanion chemistry have been developed which have 
potential for application to anthracycline synthesis. Hauser 
and Rhee (43) reported that certain benzylic sulfoxides ^  
undergo Michael addition and subsequent annelation with 
unsaturated esters to give bicyclic products 2^. Thermal 
elimination produces phenols ^ . 
:ph SPh 
24 25 
26 
Methods which use the anion of variously substituted 
phthalides have proven to be very useful.' Broom and Sammes 
(44) first reported that the anion of phthalide ^  can be 
formed with LDA (lithium diisopropyl amide) and, in a one 
27 
pot annelation reaction with unsaturated carbonyl compounds, 
produce keto-alcohols ^  in moderate yield. T'Then treated 
with acid, the keto-alcohols gave phenols ^ . 
0 9 
R' LDA/THF 
OH 0 
Further application of phthalide anions was developed 
at the same time by Kraus and Sugimoto (45) and Hauser and 
Rhee (43). Using substituted phthalide anions in the 
annelation process, hydroquinones can be obtained directly. 
Hauser and Rhee used sulfone substituted phthalides 3^, 
while Kraus and Sugimoto used cyano substituted phthalides 
31. Both processes give hydroquinones in good yield. 
OUEt 
30 S°2Ph 
70% OH 
COgEt 
. CH, 
28 
31 CN 
The mechanism proposed for this process is shown below. 
The substituent X must serve both as a good carbanion 
stabilizing group and as a good leaving group. The sulfone 
and cyano groups fit both criteria well. The use of the 
simple thiophenyl substituted phthalide for annelations 
will be detailed in the next section. 
The ability of these phthalides to undergo annelation 
reactions was utilized by a group at Syntex Research in an 
approach to the synthesis of aklavinone (46). They attempted 
using all three phthalides to add to the unsaturated 
ketones 35 and 36. They found that only the cyano 
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substituted phthalide ^  underwent the desired reaction, 
giving the annelation product in 30% yield (47). These 
tetracyclic compounds may be difficult to properly function-
alize to give aklavinone. 
^ SCUPh 
n CN^ 
SPh 
35 
COgCHg 
CHnO 
CH.O COgCHg 
Finally, a model study for the synthesis of the A ring 
portion of aklavinone has been reported (48). Reaction of 
ketoester ^  with Triton B (benzyltrimethylaramonium methoxide) 
in methanol yielded a mixture of products. The ratios of 
products were different if the hydroxide form of Triton B 
was used or if the reaction time was varied. 
COgCHg OH COgCHg 
Triton B, 
MeOH ^ 
30 
COoCH, OH CP2CH3 
OH H H 
+ 
33 R = H 21% 
^ R = CH3 24% 
The following mechanism was proposed for formation of 
products 3^. 
37 Triton B ^ 
0 £°2^ % 0 0 0 ® Ï2CH3 
Z.Q 
0 OCH 
0® q® 5O2CH3 
^ CHo m 
1) ) 33 
2) oxid. 
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RESULTS AND DISCUSSION 
Previous work from our laboratory (45) had demonstrated 
the utility of phthalide annelations for the rapid and 
efficient synthesis of quinones. We hoped to use this 
reaction as the basis for synthesizing aklavinone and 
ekatetrone. Retrosynthetic analysis indicated two possible 
routes to these molecules starting from a suitable B ring 
precursor. The first route utilized a Diels-Alder reaction 
to introduce the A ring of aklavinone. A phthalide annelation 
Route 1 
OH 
R 0 OH "QH R 0 0 
Z 
0 
would then be used to introduce the CD rings of the tetra­
cyclic system. The second route, which would be better 
suited for synthesizing ekatetrone, began with a phthalide 
annelation to a functionalized cyclohexenpne. The function­
ality on the enone would then be used in the final steps to 
form the A ring. 
32 
Route 2 
0 0 
Y 
Z 
R 0 OH 
X 
=#> 
Y 
Z 
R 0 0 
Studies were undertaken to determine the feasibility 
of using the first route for synthesizing aklavinone. An 
ideal B ring precursor might be 2,5-cyclohexadienone (^)• 
After the initial Diels-Alder reaction, the enone portion of 
the AB ring system would be used in the phthalide annelation 
Although 2,5-cyclohexadienone has been isolated and charac­
terized at -196 °C (49), it unfortunately exists in an 
unfavorable equilibrium with phenol at normal temperatures. 
If ^  was available, it would probably give some Diels-Alder 
product resulting from the addition of two molecules of the 
diene, as is often the case with benzoquinone. 
0 OH 
39 
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Because of these difficulties, we sought an equivalent 
of ^  in which one of the double bonds was protected with a 
functional group that could easily be eliminated. Since 
Ager and Fleming (50) had reported the transformation of 
g-silyl ketones to enones in good yield, enone ^  might be 
a desirable B ring precursor. We were happy to discover 
0 
EtOAc/CHCl, 
+ CuBrg 
CH3 ^  SiMeg 
that ^  had been reported in the literature (51). Compound 
^ could be readily synthesized from anisole in large 
quantities. 
MegSi 
Li/THF ^ 
Me^SiCl 
H 
Me. Si 
© ^  
SiMe, 
OCH, 
40 + r BF3'Et20 benzene 
75% 
MegSi 
0 41 
CH, 
I -^1 
0 42. 
The Lewis acid catalyzed reaction of ^  with isoprene 
gave in good yield. Attempts to use the Ager and Fleming 
conditions to form the desired bicyclic enone ^  were 
34 
unsuccessful. While the product of the reaction contained 
no silyl group, the trisubstituted olefin was also gone. A 
by-product of the reaction, HBr, may have been adding to 
the olefin. When the reaction was run in the presence of 
excess base, however, none of the desired enone ^  was 
isolated. Examples were also found in the literature where­
in CuBr2 was used for the bromination of olefins (52). 
Examination of the reactions of compounds such as ^  
and ^  indicated that the Ager and Fleming reaction was not 
at all general. Saturated hydrocarbon functional groups 
seem to be the only functional groups compatible with the 
reaction conditions. 
0 0 
CuBr2 
43 
COgCHg 
0 0 
CH 3 
^^3 44 
The bromoketone ^  was synthesized and treated with KF 
in CHgCN to give ^  in poor yield. The yield was not high 
enough for the reaction to be considered useful as the first 
35 
1) LiN(i-Pr), 
41 Z ^ 
2) Brg 
Meg Si 
KF/CH3CN 
34% overall 
->42 
part of a multi-step synthetic sequence. Alternative 
syntheses of ^  were examined. While cyclohexenone is 
reported to react with butadiene in good yield (53), none 
of the desired product ^  was obtained on reaction of 
cyclohexenone with isoprene. The reaction of isoprene with 
^ gave dimerized isoprene and the original enone as 
products. 
'42 
.CH. 
+ I BFj-EtjO 
•>  ^
PhS If benzene 
The difficulties associated with synthesizing the 
bicyclic AB units needed for the first synthetic route led 
to an examination of the use of the second route for 
synthesizing both aklavinone and ekatetrone. While cyano 
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phthalide ^  had worked well in annelation reactions (45), 
it was difficult to synthesize in quantities large enough 
to use in a multi-step synthesis. We found that on a 
reasonably large scale cyanohydrin ^  could be converted 
to cyano phthalide However, the product contained 
unidentifiable impurities which could not be removed by 
recrystallization or column chromatography. The use of 
catalysts such as trifluoroacetic acid and p-toluenesulfonic 
acid for the lactonization did not provide ^ . 
COoCH SiO 
CHCl 
SPh 
.OH 
The thiophenyl phthalide 5^ was easier to make in large 
quantities and its ability to undergo the annelation reaction 
was examined. Under the reaction conditions used for cyano 
phthalide annelation (LiN(i-Pr)2/THF/-78 °C), only Michael 
addition products were isolated (54). We examined the effect 
on the reaction of varying the reaction conditions. It was 
found that optimum yields of annelation products could be 
obtained by using two equivalents of hexamethylphosphoramide 
(HMPA), 1.5 equivalents of LiN(i-Pr)2 (LDA) and allowing the 
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reaction mixture to stir for 72 hours at 0 C. Some examples 
of products obtained from thiophenyl phthalide annelations 
are shown below. 
Unsaturated carbonyl Annelation product 
compound 
SiMe, 
51 
52 
53 
54 
SxMe 
30% 
38% 
70% 
66% 
The proposed annelation mechanism involves an initial 
Michael addition of the phthalide anion tp the unsaturated 
carbonyl compound. If the Michael adducts are very polar, 
they precipitate out of solution giving a low yield of 
annelation product. The annelation reaction with 
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cyclohexenone yielded 32% of the Michael adduct ^ . The 
annelation reaction with 5-trimethylsilyl cyclohexenone 
yielded 5-10% of Michael adduct Treatment of 5^ under 
the annelation conditions orovided 53,. 
LDA'HMPA^ 53 
THF ^ 
PhS PhS 
SiMe, 
It was found that 54 could be oxidized in one step to 
pachybasin (57), a naturally occurring fungal metabolite 
(55). Treatment of ^  with N-bromosuccinimide (NBS) 
resulted in benzylic bromination and subsequent loss of HBr 
to give a tricyclic phenol. When exposed to air, the hydro-
quinone was oxidized to the quinone. This provided a very 
efficient two step synthesis of pachybasin in an overall 
yield of 32%. 
NBS 
49% 
39 
Studies have shoTvn that 4-demethoxydaunomycin is more 
active than daunomycin (56). Elaboration of tricyclic 
compounds 53 or 54 to tetracyclic systems would give 4-
deoxyaklavinone and 4-deoxyekatetrone. It would be interest­
ing to compare the activity of these deoxy compounds to the 
naturally occurring substances. For a total synthesis of 
aklavinone and ekatetrone a method was needed for introduc­
ing the oxygen functionality in the D ring. lie felt that 
phthalide ^  would allow regiospecific introduction of the 
C-4 oxygen. 
The synthesis of ^  was a major challenge. No commer­
cially available aromatic starting material could be obtained 
which would allow elaboration to After much experimenta­
tion, a six step synthesis was developed starting with 
readily available enone ^  (57). The initial aromatization 
(58 ->• ^) worked quite well, with the allylic bromination 
and loss of HBr occurring in one pot. This appears to be 
a good method of aromatizing cyclohexenones. Treatment of 
cyclohexenones with CuBr2 in CH^CN is also reported to 
33 
40 
CH 
NBS 
m 
1) NBS 1) NBS 
2) NaCN 
83% 49% OCH 
OCH, 
60 " 
:Hr 
JOgEt 
33 
give phenols (53). In this case, reaction of ^  with 
CuBrg gave ^  in 60% yield. 
Enone 62 could be aromatized to phenol 63 in 63% overall 
yield. However, the allylic bromide would only aromatize 
after treatment with 1,5-diazabicyclo 3 . oj non-5-ene (DBN) . 
1) NBS 
COgEt 2) DBN 
6 2  
"tX.'. 
OH ^ 
63 
Transformation of 61 to 33 involved formation of the 
^ /Ni/ 
a-bromonitrile, followed by thermal elimination (155 °C/10 mm) 
of ethyl bromide to yield the lactone (59). An attempt was 
made to use this thermal elimination to synthesize the 
unsubstituted cyano phthalide but surprisingly, bromo-
nitrile 65 could not be obtained. 
41 
CN CN 
COmCH. 
64 ^ 
COgCHg 
'Br 
65 
Having obtained phthalide 3^, it was subjected to the 
annelation reaction conditions used for thiophenyl phthalide 
The results were quite disappointing. While the 
initial Michael addition appeared to take place, little or 
no annelation product could be isolated. When ^  was 
reacted with a complex product mixture was obtained. 
About a 40% yield of annelation product ^  was isolated. 
Hydroquinone ^  could not be obtained in completely pure 
form, but its structure was assigned on the basis of nuclear 
magnetic resonance (NMR) and infrared data. 
The use of phthalide ^  (60) gave no annelation products 
with 5-methyl cyclchexenone or 5-trimethylsilyl cyclo-
hexenone. Phthalide ^  has been used to prepare hydroquinone 
a key intermediate in a regiospecific synthesis of 
kalafungin ^  (61) . Again, the yield of annelation product 
SiMe 
CH3O OH 0 
66 
42 
CH CH. 30% 
+ 
SPh 34 
CH 
HO 
was quite low. Hauser and Combs used the phthalide ^  in 
a regiospecific synthesis of chartreusin aglycone ^  (62). 
The phthalide 32 also did not afford high yields of 
annelation products. 
CH-P 0 
ôv 
We felt that there were two possible reasons for the 
poor annelation results with 3^. Firstly, a certain amount 
of strain may be involved in forming the tricyclic tetra-
hedral intermediate leading to the hydroquinone. Secondly, 
the methoxyl group is an electron donating group and may 
0 69 OH 
43 
decrease the electrophilicity of the lactone carbonyl. To 
examine the first problem, the protected cyanohydrins 
and 1\ were prepared. 
Protected cyanohydrins are known to undergo Michael 
addition to unsaturated ketones (63) but no reactions of 
the anions of protected cyanohydrins containing an ortho 
carbonyl group have been reported. The compounds 7^ and 71 
were reacted with 5-methyl cyclohexenone under the standard 
annelation conditions. Compound 71 gave a low yield of 73. 
46% 
OEt 0 v^O
CN CH3 
70 
CO2CH, 
(Me) 2 t-Bu 
71 
/—OEt 
72 
I 
+ 
CN NC 0Si(Me)2t-Bu 
73 
This was due to the instability of the silyl protecting 
group under the reaction conditions. Compound which was 
more stable to the reaction conditions, gave a fair yield 
of 72. Some thioacetals are also known to add to unsaturated 
carbonyl compounds (64). The reaction between 74 and 
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5-methyl cyclohexenone gave a 37% yield of annelation 
product 1^ . 
A similar reaction sequence was attempted by Parker 
and Kallmerten (65). They were unable to obtain Michael 
addition products from the reaction of 76a and 76b with 77. 
Z = Y = SCHgCHgCHgS 
7^b Z = CN Y = 0CH(CH3)0Et 
Our results seemed to indicate that strain is not the 
major problem, since the annelations involving the protected 
cyanohydrins and thioacetal gave lower yields of product 
with 5-methyl cyclohexenone than did phthalide ^ . The 
electron donating effect of the methoxyl group is probably 
the major factor interfering with the annelation process. 
An attempt was made to synthesize phthalide 80 from 59. 
75 
Z Y Z Y 
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The electron withdrawing phenylsulfonyloxy group would be 
expected to maintain or increase the electrophilicity of 
the lactone carbonyl. Transformation of 78 to 79 occurred 
59 r 1) NBS 
oust NaH ^^%^C02Et 2) NaCN 
OSOgPh OSOgPh 
78. rw 79 
PhOgSO 
^ 80 
in 12% overall yield. Both steps produced significant 
amounts of unidentifiable side products. Because of the low 
overall yield, no effort was made to transform 79 into 80. 
The elaboration of a tricyclic hydroquinone to deoxy-
aklavinone and deoxyekatetrone was our next goal. We felt 
that compound ^  would be a key intermediate for both 
syntheses. 
We decided to use the known reactivity of aryl silanes 
in an effort to synthesize 81. Hydroquinone ^  could be 
protected as its dimethyl ether 8^ in excellent yield. 
Benzylic bromination gave aromatized product The loss 
of the silyl group was not unexpected. Phenol ^  could be 
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OCH3 COgR 
CHO 
OCH3 OCH3 
CH3CNR2 /base ^ base 
OCH OCH3 ^"3 COR2 
OCH3 OCH3 OH 
4-deoxyekatetrone 4-deoxyaklavinone 
OCH, 
53 
(CH3)2S0^ 
K2CO3/acetone 
OCH, 
SiMe, 
OCH3 0 
82 
NBS 
82 > 
75% 
HNO3/HOAC 
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oxidized to the known quinone To obtain the desired silyl 
phenol, transformations which would not generate a cation 
beta to the silyl group had to be used. Enol silyl ether 
85 could be prepared in quantitative yield. It was trans­
formed into an a-thiophenyl ketone and oxidized with m-chloro-
peroxybenzoic acid (MCPBA) to the sulfoxide without isolation 
of the thiophenyl ketone. The sulfoxide elimination 
occurred ^  situ between 0 °C and room temperature to give 
phenol 8^ in an overall yield of 57%. Generally, sulfoxide 
eliminations take place at temperatures near 100 °C. 
OCH OCH 
iMe iMe 
1) LDA 1) PhSCl, 
> 
2) MCPBA 
OCH. OSiMe 
S iMe (CH.).SO, 
86 ^> 
^ KmCO./acetone 
CH, 
Aryl silanes are known to undergo a number of electro-
philic substitution reactions at the carbon bearing the 
silicon (66, 67a). We hoped to replace the trimethylsilyl 
group of ^  with either a halogen or an acyl group. The 
halogen or acyl group would then be transformed into the 
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acetic acid ester side chain of key intermediate 81. 
Reactions of 8^ were performed with Brg (67b), I2 (67c) and 
ICI (67d). In every case, either starting material was 
recovered or halogenation appeared to occur at other posi­
tions on the aromatic system, Friedel-Crafts acylation with 
acetyl chloride (66) was also attempted, but only starting 
material was recovered. Apparently, carbons other than the 
one bearing the silicon are more activated toward substitu-
X = Br, I or CR 
We then looked for an alternative synthetic application 
for We had shown that the silyl group allowed a mild 
and high yield transformation of the ketone to a phenol 
(8^ -»• ^). We decided to introduce a functional group alpha 
to the ketone which, after aromatization, would facilitate 
metalation of the ortho position and thus allow introduction 
of the desired functionality. 
A number of oxygen and nitrogen containing functional 
groups have been shown to facilitate ortho metalation of an 
aromatic ring (68). We hoped to introduce such a group via 
the enolate of 82. While the synthesis of enol silyl ether 
tion. 
COgR 
0 OCH, OCH-
II j 3 OCH3 OCH3 
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OCH, OCH, 
SiMe, 
OCH3 0 
8^ 
88^  
88d 
88e 
X 
CHO 
COgR 
CHgOH 
CHgNRg 
OCH3 COgR 
CONHSOgPhCg-CHg) OCH3 OR 
^ demonstrated that the enolate could be made, the enolate 
proved to be extremely unreactive. The enolate would not 
participate in aldol condensations, alkylations, acylations 
or Mannich reactions. ' Apparently, the steric bulk of the tri-
methylsilyl group hinders the approach of an electrophile 
to the enolate. In only one case,were we able to introduce 
a potentially suitable functional group alpha to the ketone. 
Under mild conditions, enol silyl ethers are known to 
react with sulfonyl isocyanates to give g-keto amides (69). 
Enol silyl ether ^  reacted with £-toluenesulfonyl isocyanate 
to give 8^. The ketone could be aromatized in excellent 
yield to the phenol ^. Diethyl amides are especially useful 
for promoting ortho metalation (68), but attempts to trans­
form the sulfonyl amide into a diethyl amide by heating with 
diethyl amine or by conversion first to the acid were 
unsuccessful. 
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85 
Br2/CH2Cl2 
90% 
NHSOgPhCE-CHg) 
NHSOgPhCg-CHg) 
At this point it was decided that the trimethylsilyl 
group was more of a hindrance than a help. We then returned 
to tricyclic hydroquinone The methyl group was not 
expected to hinder functionalization of the ketone. After 
formation of the dimethyl ether the enolate could be 
easily acylated with diethyl carbonate to give 91. 
OCH 
(CH-)2S0, 
K2CO2/acetone 
OCH 
NaH/THF^ 
(EtO)2CO> 
90 
OCH3 0 
OCH 
OCH- 0 
91 
C02Et 
91 
CO^Et 
92 
OCH3 OH 
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Finding a method fçr aromatization of ^  was much more 
difficult than we originally anticipated. Benzylic bromina-
tioh, followed by treatment with DBN or quinoline did not 
give the desired phenol. The bromine must have added trans 
NBS 
91 
OCH3 5 
DBN 
•> 92 
93 
OCH3 0 
COgEt 
to the methyl group, thus, preventing the base promoted 
elimination. The a-bromoketone, formed by addition of Brg 
to 91, also did not give 92 when treated with base. 
(CHq)oSO/ 
91 3 2 4^ . 
K2CO3/acetone COoEt COgEt 
OCH3 OCH3 
94 
OCH3 OCH3 
95 
The methyl enol ether ^  could be aromatized by treat­
ment with 2,3-dichloro-5,6-dicyano-l,4-benzoquinone (DDO) 
in only 33% yield. We felt that a thermal sulfoxide 
elimination should provide ^  in a much higher yield. Treat­
ment of the sodium enolate of ^  with phenylsulfenyl chloride 
followed by oxidation gave the crude sulfoxide %. After 
prolonged heating in high boiling solvents, none of the 
desired phenol was obtained. Apparently, the sulfide added 
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91 1) NaH/THF^ 
2) PhSCl 
3) MCPBA 
^CHa 
ix\\C02Et —^^ 92 
SPh 
II OCH3 0 
to the enolate from the same side as the methyl group, A 
cis hydrogen beta to the sulfoxide is necessary for the 
thermal elimination to occur. The stereochemical outcome 
of this type of addition has also been observed in similar 
systems (97 -»• 98) by Zima and coworkers (70) . 
Knowing the stereochemistry of the intermediate a-keto 
sulfide, we thought that oxidation to the sulfone followed 
by a base induced trans elimination would yield the desired 
phenol. In fact, oxidation of the sulfide with two 
equivalents of MCPBA at room temperature or in refluxing THF 
provided phenol 92 directly. Oxidation at 0 °C gave only 
the sulfone 99. Sulfone 99 did not give 92 when heated with 
DBN, but when ^  was heated in the presence of m-chloro-
benzoic acid the phenol was formed. Therefore, elimination 
0 
n 98 
53 
to give ^  is an acid promoted process. The acid is 
provided as the by-product of the oxidation. This afforded 
an extremely efficient one pot conversion of ketone ^  to 
phenol ^ . 
1) NaH/THF 
2) PhSCl 
3) 2 MCPBA 
Having the tricyclic aromatic system ^  in hand, methods 
were investigated for transforming ^  into the desired key 
intermediate Ethyl 2-methoxy-6-methyl benzoate (6^) was 
used as a model system for the transformation. The ability 
of the ester to stabilize carbanion formation (71) allowed 
synthesis of diester 100. Using a method developed in our 
laboratory for the selective reduction of esters in the 
presence of other carbonyl functionality (72) , we hoped to 
selectively reduce the ethyl ester to an alcohol 101. 
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Careful oxidation would then yield the desired aldehyde 
ester 102. Unfortunately, only a small amount of the lactone 
derived from 101 could be isolated. 
CPoCH 
1) LDA 1) LDA 
60 > 
^ 2) (MeO),CO COoEt LiAlH 
OCH 
100 
101 
CHO 
OCH3 
IQ3 
It is known that esters, nitriles and some amides will 
allow carbanion formation and subsequent functionalization 
of an ortho methyl group on an aromatic ring (68). The use 
of an aldehyde in this process has never been reported. 
CH CH 
LiAlH 
•> 
chlorochromate Et20 CHO 
OCH OCH 
103 104 
When aldehyde was treated with LDA at -78 °C in THF, a 
dark colored solution resulted. This was indicative of 
anion formation. However, after addition of carbon dioxide 
only unreacted starting material was isolated. 
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A number of aldehyde derivatives have been used to allow 
metalation of an aromatic ring. The imidazolidine deriva­
tive has been reported to allow metalation on the ring 
(10^ ->• 106) and on an ortho methyl group (107 1J08) (73) . 
105 
1) n-BuLi 
2) E 
3) H® 
CV'CHO 
106 
1) n-BuLi 
2) E 
3) H © 
CHO 
Attempted metalation of the aldehyde derivative 109, followed 
by addition of methyl iodide, gave 1^ and a trace of the 
expected isomer 104. The conformation of the imidazoli-
1) n-BuLi 
CHO 3) H© CH, 
OCH CH-0 
CH 110 109 
OCH, 
104' 
dine ring that is necessary to allow metalation must not be 
attainable when an ortho substituent such as a methoxyl group 
is present. Because a methoxyl group can also facilitate 
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ortho metalation (68), the observed product was obtained. 
It was hoped that the necessary conformation of the imidazol-
idine was not so badly disturbed that the desired metalation 
might occur with aldehyde derivative HJ. Unfortunately, 
no reaction occurred. While dimethyl acetals of aromatic 
CH, 
1) n-BuLi 
>- N.R. 
2) CH3I 
3) H ©  CHoO 
aldehydes have been used for ortho metalations, it has been 
reported that the presence of any functional group ortho to 
the acetal completely hinders the metalation (74). Again 
this must be due to steric factors. 
At this point,: it became obvious that carbanion chemistry 
would not allow the direct synthesis of 102. A recent 
result by Cowell and Stille (75) had shown that benzylic 
halides could be efficiently carboalkoxylated using a 
palladium catalyst. This would have been a nice method for 
obtaining the desired aldehyde ester. However, recent work 
by Cheung (76) had shown that when a variety of substituted 
tolualdehydes were treated with NBS, only, acid bromides were 
isolated. 
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CHO 
COoR 
OCH, 
112" 
OCH, 
A Wittig reaction gave compounds j^3a and 1^3b. Using 
the Cowell and Stille method, the ester could be introduced 
in good to excellent yield. Hydrolysis gave the acid nitrile 
Br 
CH. 
104 I II " > a J 'I, CH 
n3a R = CN 
113b R = C02Et 
CHoO 
Ujg R = CN 
114a R = COgEt 
COgCHg 
CH.O 
U5a R = CN 
n5b R = COgEt 
CO.H 
CH.O 
116a R = CN 
116b R = CO.H 
CH.O 
n. r 
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]lj.6a or the diacid It was hoped that after lactoniza-
tion the acid or nitrile could be transformed into an amide. 
This would provide a model for the AB ring system of 
deoxyekatetrone. Treatment of the acids 11^ and with 
base (77a) gave back starting material. Attempted bromo-
lactonization (77b) resulted in ring halogenation. Seleno-
lactonization (77c) and mercuric ion promoted lactonization 
(77d) also failed. Apparently, the unsaturated side chain 
is oriented perpendicular to the aromatic ring to avoid 
steric interactions with the two ortho substituents. This 
must make it difficult to attain the conformation necessary 
for lactonization. 
A biomimetic route to the aklavinone AB ring system 
was next examined. The addition of the carbanion of ethyl 
acetate to ^ should give g-keto ester 1^ which might 
further be transformed to 117. The benzylic hydrogens of 
^ are sufficiently acidic that anion exchange occurred when 
^ was added to excess lithio ethyl acetate. Only starting 
material was isolated. An intramolecular method for 
COgR 
LiCH.COgEt 
60 ^ > 
59 
introducing a two carbon unit was also tried. The acetate 
of ^  was made. Attempts to use LDA to form coumarin 1^ 
led to isolation of ^ . Potassium hydride promoted cycliza-
tion also failed. 
Compound 122a,b could be prepared from homophthalic 
anhydride 1^. V/bile 12£a rapidly decomposed to the anhydride 
upon exposure to air, compound 122b was much more stable. 
121 122a R = SiMe 
122^ R = CHg 
Extension of this reaction to anhydride 3^ would give ITÂ. 
Selective reactions at the unprotected carbonyl group will 
60 
OCH 
^3 ^ 
provide a route to a B ring unit with the desired function­
ality. This will allow formation of the AB systems for 
deoxyaklavinone and deoxyekatetrone. 
1) LiCH,CO«t-Bu 
124 
CO2Ç-BU OCH OCH 
CNH 
OCH 1) hydride 
124 
IHO 
OCH 
OH 
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CONCLUSION 
The utility of phthalide annelations for the rapid 
generation of polycyclic aromatic systems has been demon­
strated. The 3-thiophenyl and 7-methoxy-3-cyano phthalides 
were successfully used for the first time in annelation 
reactions. The use of protected o-carboxymethyl cyanohydrins 
and an o-carboxyethyl thioacetal in the annelation process 
was also reported for the first time. A phthalide annela­
tion initiated a very efficient two step synthesis of 
pachybasin. An intermediate in the pachybasin synthesis 
was functionalized to give a tricyclic aromatic system 
which should be useful for elaboration to both aklavinone 
and ekatetrone and their deoxy analogues. The annelation 
reaction of phthalides is especially applicable to the 
synthesis of 11-deoxyanthracyclines, but should also provide 
an efficient approach to the synthesis of other natural 
products containing quinones. 
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EXPERIMENTAL 
Infrared spectra were obtained on a Beckman IR 4250 
or Acculab 2 spectrometer. The NI4R spectra were recorded 
using a Varian EM-360 or A-60 spectrometer. All chemical 
shifts are reported in 6 relative to tetramethylsilane as 
13 
an internal standard. The C spectra were recorded using 
a Jeol FX-90Q spectrometer. The chemical shifts are reported 
in ppm relative to the central peak of CDClg (77.06 ppm). 
An AEI-MS902 mass spectrometer was used for mass spectral 
data. Melting points were determined on a Fisher-Johns melt­
ing point apparatus and are uncorrected. Elemental analyses 
were performed by Galbraith Laboratories, Inc. Tetrahydro-
furan and diethyl ether were distilled from LiAlH^ prior to 
use. 
Attempted Preparation of 3-Cyano Phthalide (M) 
To a solution of 5.5 g (29 mmol) of crude ^  in 100 mL 
of CHCI3 was added 20 g of silica gel (Davison 60-200 mesh, 
grade 62), The mixture was stirred at room temperature for 
72 hours. The silica gel was filtered and the filtrate 
was concentrated to yield 3.92 g of a yellow solid. NMR 
(6.10 (s, 1 H)), IR (1790 cm"^) and TLC comparison with 
authentic material (45) indicated that the major component 
of the crude product was the desired phthalide 31. No 
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unreacted cyanohydrin remained. An unidentifiable aromatic 
impurity could not be removed by recrystallization or 
chromatography. 
Preparation of 3-Cyano-7-methoxy Phthalide (^) 
To a solution of 6.57 g (30 mmol) of ^  in 60 mL of CCl^ 
was added 5.34 g (30 mmol) of NBS and a few crystals of 
benzoyl peroxide. The mixture was refluxed for 16 hours. 
After cooling to room temperature, the mixture was filtered 
and the solvent was evaporated under reduced pressure to 
give the crude a-bromonitrile (NMR (CDCl^) 1.40 (t, 3 H, J = 
6 Hz), 4.40 (q, 2 H, J = 6 Hz), 6.88 (s, 1 H), 6.82-7.50 
(m, 3 H)). The crude a-bromonitrile was placed in a one-
necked flask equipped with a magnetic stirring bar and the 
pressure was reduced to 10 mm. The flask was then immersed 
in a preheated silicon oil bath (bath temperature 155 °C) 
and heated with stirring for 45 minutes. After cooling, 
the crude product was chromatographed on silica gel using 
hexane/ethyl acetate (3:2) as the solvent. Chromatography 
provided 2.78 g (14.7 mmol, 49%) of 33 (mp 147-148.5 °C). 
NMR (dg-acetone/dg-DMSO) 4.03 (s, 3 H), 6.58 (s, 1 H), 
7.21-8.02 (m, 3 H). IR (Nujol) cm'^ 1785. High resolution 
mass spectrum for C^gHyNOg requires 189.04260; measured 
189.04205. 
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Preparation of 5-Trimethylsilyl-2-cyclohexen-l-one (^) 
To a solution of 32.6 mL (300 mmol) of anisole and 
153 mL (1200 mmol) of Me^SiCl in 150 mL of THF was added 
6.3 g (900 mmol) of lithium wire cut into small pieces. 
The mixture was stirred under Ng at room temperature for 
7-9 days, or until all of the lithium had dissolved. The 
mixture was filtered under Ng and the THF and excess Me^SiCl 
were distilled off under N2. The crude product was imme­
diately dissolved in 150 mL of H20/acetone (1:1) at 0 °C 
which had been adjusted to pH 2 by addition of dilute HCl. 
After stirring the solution overnight at room temperature, 
the acetone was evaporated under reduced pressure and the 
aqueous solution was extracted with methylene chloride. 
The organic solution was washed with brine, dried over 
NagSO^ and concentrated to give a clear yellow oil. NMR and 
IR analysis showed that the product was a mixture of a,6 and 
e,Y unsaturated ketones. The crude product was dissolved in 
250 mL of acetone and 2 mL of concentrated HCl was added. 
The solution was refluxed overnight. After the solvent was 
evaporated, the residue was dissolved in methylene chloride 
and was washed with saturated sodium bicarbonate. The 
organic solution was then washed with brine, dried over 
NagSO^ and concentrated ^  vacuo. Careful chromatography on 
silica gel using hexane/ether (5:1) as the solvent gave a 
pale yellow oil. The oil was Kugelrohr distilled (105 °C/10 
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mm) to give 23.3 g (139. mmol, 46%) of NMR (CDClg) 0.05 
(s, 9 H), 2.31-2.70 (m, 5 H), 6.20 (d, 1 H, J = 10 Hz), 7.25 
(m, 1 H). IR (film) cm~^ 1675. High resolution mass 
spectrum for CgH^gOSi requires 168.09705; measured 168.09684. 
Preparation of 3,4,4a,5,8,8a-Hexahydro-6-methyl-3-
trimethylsilyl-1 (2H) -naphthalenone (^) 
To a solution of 3.36 g (20 mmol) of ^  in 20 mL of 
benzene was added 6.0 mL (60 mmol) of isoprene and 0.25 mL 
(2 mmol) of BFg'EtgO. The solution was stirred at room 
temperature for 7 days. The solution was concentrated to 
give an oil which was chromatographed on silica gel using 
hexane/ether (10:1) as the solvent. The reaction afforded 
3.6 g (15.1 mmol, 75%) of NMR (CDCI3) 0.00 (s, 9 H) , 
1.60 (br s, 3 H), 1.70-2.90 (m, 11 H), 5.40 (m, 1 H). IR 
(film) cm"^ 1700. High resolution mass spectrum for 
^14^24^^^ requires 236.159649; measured 236.160853. 
Preparation of 4,4a,5,8-Tetrahydro-6-methyl-l(8aH)-
naphthalenone (4^ 
To a 1 M THF solution of 3.0 mmol of LDA (78) at -78 °C 
under Ng was added 0.71 g (3.0 mmol) of 41 in 3 mL of THF. 
After stirring for 15 minutes at -78 °C, 0.16 mL (3.0 mmol) 
of bromine in 3 mL of methylene chloride was added and the 
solution was stirred for an additional one minute. The 
reaction was quenched by dilution with ether and washing 
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with 30 mL of water containing 3.0 mmol of acetic acid. 
The organic solution was washed with brine, dried over 
NagSO^ and concentrated. The crude bromide ^  (0.8 g, 2.5 
mmol) was immediately dissolved in 5 mL of acetonitrile. 
Potassium fluoride (0.24 g, 2.5 mmol) was added and the 
mixture was stirred overnight at room temperature. The 
mixture was diluted with ether and th^n was washed with 
water. The organic solution was dried over Na2S0^, filtered 
and concentrated ^  vacuo. The crude product was 
chromatographed on silica gel using hexane/ether (5:1) as 
the solvent. Chromatography gave 0.15 g (0.93 mmol, 34% 
overall yield) of NMR (CDCI3) 1.65 (br s, 3 H), 1.80-
2.90 (m, 8 H), 5.40 (m, 1 H), 6.00 (d, 1 H, J = 10 Hz), 
6.90 (m, 1 H). IR (film) cm'^ 3020, 1670. High resolution 
mass spectrum for requires 162.10447; measured 
162.10444. 
Attempted Preparation of 5-Carboethoxymethyl-2-cyclo-
hexen-l-one from 5-Carboethoxymethyl-3-trimethylsilyl 
Cyclohexenone (^) 
To a solution of 0.24 g (1.0 mmol) of 43 in 5 mL of 
chloroform/ethyl acetate (1:1) was added 0.45 g (2.0 mmol) 
of CuBr2. The mixture was refluxed for 7.hours. The result­
ing solution was washed with 10% NagCO^ and then with brine. 
The organic solution was dried over Na2S0^, filtered and 
concentrated vacuo. The crude product contained no silyl 
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group. The NMR spectrum indicated the presence of a double 
bond, but the position of the double bond could not be 
determined from the spectrum. It was clear though that 
none of the desired enone was obtained. 
Attempted Preparation of 6-Methoxy-6-methyl-2-decalen-
1-one from 6-Methoxy-6-methyl-3-trimethylsilyl-l-
decalone (^) 
To a solution of 0.27 g (1.0 mmol) of 4^ in 5 mL of 
chloroform/ethyl acetate (1:1) was added 0.45 g (2.0 mmol) 
of CuBrg. The mixture was refluxed for 2 hours. The 
resulting solution was washed with 10% Na^COg and then with 
brin'e. The organic solution was dried over NagSO^, filtered 
and concentrated m vacuo. The crude product contained no 
methoxyl group and the spectra were the same as those 
obtained from the product of the reaction of ^  with CuBr2. 
Preparation of 6-Thiophenyl-2-cyclohexen-l-one (48^ 
To a 1 M solution of 64 mmol of LDA at -78 °C under Ng 
was added 5.8 mL (60 mmol) of 2-cyclohexen-l-one in 60 mL 
of THF. After stirring the mixture for 20 minutes at 
-78 °C, a 2 M THF solution of a mixture of 11.5 mL (90 mmol) 
of Me^SiCl and 13.3 mL (90 mmol) of EtgN was added. When 
the addition was complete, the reaction solution was allowed 
to warm to 0 °C and was stirred for 1 hour, ihe reaction 
mixture was poured into 350 mL of pentane and was rapidly 
68 
washed with cold 0.5 N HCl and then brine. The organic 
solution was dried over NagSO^, filtered and concentrated 
in vacuo to give the enol silyl ether. 
The crude enol silyl ether was dissolved in 120 mL of 
methylene chloride. The solution was cooled to -60 °C 
and 35.1 mL of a 1.71 M benzene solution of phenylsulfenyl 
chloride was added slowly. When the addition was complete, 
the solution was warmed to room temperature and was stirred 
for 1 hour. The solvent was evaporated and the residue 
was chromatographed on silica gel using hexane/ether (6:1) 
as the solvent. The reaction provided 7.25 g (35.5 mmol, 
59%) of 48 as a viscous orange oil. NMR (CDClg) 1.80-2.80 
(m, 4 H), 3.85 (m, 1 H), 6.00 (d, 1 H, J = 10 Hz), 6.90 
(m, 1 H), 7.10-7.70 (m, 5 H). IR (film) cm"^ 3060, 1680. 
Preparation of Phenylsulfenyl Chloride 
To a suspension of 33.5 g (250 mmol) of N-chlorosuccini-
mide in 60 mL of benzene at 0 °C was slowly added dropwise a 
solution of 20.5 mL of benzenethiol in 40 mL of benzene. 
The mixture was stirred overnight at room temperature. The 
reaction mixture was filtered and the filtrate was con­
centrated vacuo. The residue was distilled (87 °C/16 mm) 
to give a dark red oil (18.4 g, 127 mmol,- 64%) that could 
be stored for several months at 0 °C as a solution in either 
methylene chloride or benzene. 
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Preparation of Methyl-1'-cyano-2-hydroxymethyl Benzoate (^) 
To a solution of 5.7 g (55 mmol) of sodium bisulfite 
in 50 mL of water was added 8.2 g (50 mmol) of methyl-2-
formyl benzoate (79). Ether (50 mL) was added and the 
solution was cooled to 0 °C. A solution of 2.7 g (55 
mmol) of NaCN in 15 mL of water was added dropwise. After 
the mixture had been stirred for 1% hours at 0 °C, the 
layers were separated and the aqueous layer was extracted 
with ether. The organic solution was washed with brine, 
dried over Na2S0^ and evaporated vacuo. A waxy solid ^  
(5.6 g, 29 mmol, 58%) was obtained. NMR (CDClg) 4.00 (s, 
3 H), 5.88 (s, 1 H), 7.25-8.20 (m, 4 H). IR (Nujol) cm"^ 
3350, 2255, 1715. 
Preparation of 3-Thiophenyl Phthalide (50) 
A few crystals of g-toluenesulfonic acid were added to 
a solution of 30.0 g (200 mmol) of o-carboxybenzaldehyde 
and 20.5 mL (200 mmol) of thiophenol in 200 mL of benzene. 
The solution was refluxed for 48 hours with removal of 
water in a Dean Stark trap. The solution was cooled and 
concentrated ^  vacuo to yield 47.4 g (196 mmol, 98%) of 
crystalline ^  (mp 101-102 °C, lit. (80) 100-102 °C). The 
product was sufficiently pure for immediate use. NMR 
(CDCI3) 6.85 (s, 1 H), 7.30-8.00 (m, 9 H). IR (CHCI3) 
cm"^ 1780. 
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General Procedure for the Reaction of 3-Thiophenyl 
Phthalide with Michael Acceptors; Preparation of 3,4-
Dihydro-5, lO-dihydroxy-3-methyl-1(2H) -anthracenone (^) 
A solution of LDA'HMPA complex (81) was prepared by 
adding 10.4 mL (60 mmol) of HMPA in 20 mL of THF to a 1 M 
THF solution of LDA (45 mmol) at -78 °C under N2. After 
the solution had been stirred for 20 minutes at -78 °C, a 
solution of 7.26 g (30 mmol) of 50 in 30 mL of THF was 
added dropwise to give a reddish-brown solution. After 
30 minutes at -78 °C, a solution of 3.3 g (30 mmol) of 5-
methyl cyclohexenone in 30 mL of THF was added dropwise. 
The solution was stirred for 1 hour at -78 °C and then 72 
hours at 0 °C. The reaction mixture was then diluted 
with water, neutralized with dilute acetic acid and 
extracted with ethyl acetate. The organic solution was 
washed with brine, dried over Na2S0^, filtered and concen­
trated vacuo. The residue was chromatographed on silica 
gel using hexane/ether as the solvent to yield 4.8 g (19.8 
mmol, 66%) of 54 (mp 172-173 °C). NMR (CDCI3) 1.15 (d, 
3 H, J = 6 Hz), 2.00-3.45 (m, 5 H), 7.10-8.40 (m, 4 H). 
IR (Nujol) cm"^ 3220, 1610. High resolution mass spectrum 
for C^gH^^Og requires 242.094298; measured 242.09351. 
2-Acetyl-1,4-dihydroxynaphthalene (51) 
On an 8 mmol scale, compound ^  (mp 134-136 °C) was 
produced in 30% yield. NMR (CDCl^) 2.57 (s, 3 H), 2.68 
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(s, 3 H), 7.30-8.60 (m, 4 H). IR (Nujol) cm'^ 3410, 1620. 
This material was identical to a sample prepared by an 
independent method (82). 
3,4-Dihydro-5,10-dihydroxy-l(2H) -anthracenone (52.) 
On a 3 mmol scale, compound ^  (mp 169-171 °C) was 
obtained in 38% yield. NMR (CDCI3) 1.90-3.20 (m, 6 H), 
7.00-8.40 (m, 4 H). IR (Nujol) cm"^ 3320, 1620. High 
resolution mass spectrum for requires 228.07865; 
measured 228.07758. Compound 5^ (54) was also produced 
in 32% yield from this reaction. NMR (CDCl^) 1.70-3.00 
(m, 9 H), 7.10-7.90 (m, 9 H). IR (Nujol) cm"^ 1780, 
1715. 
3,4-Dihydro-5,10-dihydroxy-3-trimethylsilyl-l(2H)-anthracen­
one (53) 
On a 30 mmol scale, compound ^  (mp 150-152 °C) was 
prepared in 70% yield. NMR (CDCl^) 0.10 (s, 9 H), 2.40-3.60 
(m, 5 H), 7.40-8.60 (m, 4 H). IR (Nujol) cm"^ 3400, 1605. 
High resolution mass spectrum for C2yH2Q02Si requires 
300.11818; measured 300.11817. Compound ^  was also 
produced in 5-10% yield from this reaction. NMR (CDClg) 
0.05 (s, 9 H), 1.70-3.00 (m, 8 H), 7.10-7.90 (m, 9 H). 
IR(Nujol) cm'l 1760, 1705. 
Preparation of Pachybasin (^) 
To a solution of 0.97 g (4 mmol) of hydroquinone ^  in 
20 mL of CCI4 was added 0.71 g (4 mmol) of NBS and a few 
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crystals of benzoyl peroxide. The mixture was refluxed for 
10% hours. On cooling to room temperature, a solid pre­
cipitated out of solution. The reaction mixture was 
diluted with ethyl acetate, washed with water and then 
brine, and dried over NagSO^. The solvent was evaporated 
in vacuo and the residue was chromatographed on silica 
gel using hexane/methylene chloride (2:1) as the solvent 
to give 0.46 g (1.92 mmol, 48%) of pachybasin (mp 178-
180 °C, lit. (55) 176-177 °C). NMR (CDCI3) 2.40 (s, 3 H), 
7.00-8.40 (m, 6 H). IR (Nujol) cm"^ 1670, 1640, 1590. 
Preparation of Ethyl 2-Hydroxy-6-methyl Benzoate (6£) 
To a solution of 9.1 g (50 mmol) of ethyl 6-methyl-2-
0x0 cyclohex-3-ene carboxylate (57) in 100 mL of CCl^ was 
added 8.9 g (50 mmol) of NBS and a few crystals of benzoyl 
peroxide. The mixture was refluxed for 18 hours. After the 
reaction mixture had cooled to room temperature, it was 
filtered and the solvent was evaporated in vacuo. 
Chromatography of the residue on silica gel using hexane/ether 
(30:1) as the solvent provided 7.2 g (40 mmol, 80%) of ^  
(mp 39-40 °C). NMR (CDCI3) 1.4 (t, 3 H, J = 6 Hz), 2.53 
(s, 3 H), 4.38 (q, 2 H, J = 6 Hz), 6.58-7.38 (m, 3 H), 11.21 
(s, 1 H). IR (Nujol) cm"^ 3400, 1655, 1605. 
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Preparation of Ethyl 2-Methoxy-6-methyl Benzoate (^) 
To a solution of 11.0 g (61 mmol) of ^  in 800 mL of 
acetone was added 12.6 g (91.5 mmol) of potassium carbonate 
and 8.65 mL (91.5 mmol) of dimethyl sulfate. The mixture 
was reflxixed for 16 hours. After cooling to room 
temperature, the reaction mixture was filtered and concen­
trated vacuo. The residue was chromatographed on silica 
gel using hexane/ether (30:1) as the solvent. Chromatography 
afforded 10.9 g (56 mmol, 92%) of 60. NMR (CDCI3) 1.34 (t, 
3 H, J = 6 Hz), 2.29 (s, 3 H), 3.80 (s, 3 H), 4.35 (q, 2 H, 
J = 6 Hz), 6.60-7.30 (m, 3 H). IR (film) cm"^ 1725, 1585. 
Preparation of Ethyl 2-Cyanomethyl-6-methoxy Benzoate (^) 
To a solution of 22.6 g (116.4 mmol) of ^  in 230 mL 
of CCl^ was added 20.8 g (117 mmol) of NBS and a few 
crystals of benzoyl peroxide. The mixture was refluxed 
for 8 hours. After cooling to room temperature, the mixture 
was filtered and the solvent was evaporated m vacuo to 
give the crude benzylic bromide (NMR (CDCl^) 1.40 (t, 3 H, 
J = 6 Hz), 3.81 (s, 3 H), 4.40 (q, 2 H, J = 6 Hz), 4.49 
(s, 2 H), 6.75-7.55 (m, 3 H)). To a solution of the crude 
benzylic bromide in 60 mL of 95% EtOH was added a solution 
of 6.88 g (140.4 g) of NaCN in 70 mL of HgO. The result­
ing solution was refluxed for 4 hours. The EtOH was 
evaporated under reduced pressure and the aqueous residue 
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was extracted with ether. The ethereal solution was washed 
with brine and dried over Na2S0^. After evaporating the ether 
in vacuo, the residue was chromatographed on silica gel 
using hexane/ether (10:1) as the solvent. Chromatography 
gave 7.64 g (39.4 mmol) of unreacted ^ and 14.1 g (63.9 
mmol) of 61. The corrected yield was 83%. NMR (CDClg) 
1.40 (t, 3 H, J = 6 Hz), 3.75 (s, 2 H), 3.83 (s, 3 H), 4.40 
(q, 2 H, J = 6 Hz), 6.82-7.50 (m, 3 H). IR (film) cm"^ 
2225, 1725, 1580. High resolution mass spectrum for 
C12H13NO3 requires 219.08955; measured 219.08945. 
Preparation of Ethyl 4-Bromo-2-hydroxy-6-methyl Benzoate (^) 
To a solution of 1.8 g (7 mmol) of ethyl 4-bromo-6-
methyl-2-oxo cyclohex-3-ene carboxylate (6^ (83) in 15 mL 
of CCl^ was added 1.25 g (7 mmol) of NBS and a few crystals 
of benzoyl peroxide. The mixture was refluxed 24 hours. 
After cooling to room temperature, the reaction mixture was 
filtered and the solvent was evaporated ^  vacuo. The residue 
was dissolved in 10 mL of benzene and 1.8 mL (14 mmol) of 
DBN was added. The solution was refluxed overnight. On 
cooling to room temperature, the reaction mixture was 
diluted with water and acidified. The aqueous layer was 
extracted with ether and the combined organic extract was 
washed with brine and dried over Na2S0^. The solvent was 
evaporated under reduced pressure. Chromatography of the 
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residue on silica gel using hexane/ether (10:1) as the solvent 
gave 1.15 g (4.4 mmol, 63%) of ^  (mp 42.5-44 °C). NMR 
(CDCI3) 1.40 (t, 3 H, J = 6 Hz), 2.45 (s, 3 H), 4.35 (q, 2 H, 
J = 6 Hz), 6.75 (br s, 1 H), 6.94 (br s, 1 H), 11.45 (s, 
1 H). IR (CHCI3) cm"l 3300, 1660, 1600. High resolution 
mass spectrum for C^gH^gErOg (loss of H) requires 257.98921; 
measured 257.98911. 
Preparation of 3,4-Dihydro-5,lO-dihydroxy-9-methoxy-
3-trimethylsilyl-l(2H)-anthracenone (6^) 
Phthalide ^  was reacted with 5-trimethylsilyl cyclo-
hexenone on a 3 mmol scale using the conditions for thio-
phenyl phthalide annelations. Chromatography provided 40% of 
^ which could not be completely purified. NMR (CDClg) 0.50 
(s, 9 H), 2.10-2.85 (m, 5 H), 4.02 (s, 3 H), 7.05-8.00 (m, 
3 H), 12.80 (s, 1 H), 14.60 (s, 1 H). IR (CHCI3) cm"^ 3400, 
1625, 1580. 
Preparation of Methyl 2-(1 *-Cyano-3'-methyl-2',4'-
dioxahexyl) Benzoate (^) 
To a solution of 1.73 g (9.0 mmol) of ^  and 2.86 mL 
(30 mmol) of ethyl vinyl ether in 20 mL of methylene chloride 
was added 0.4 g of pyridinium £-toluene sulfonate. The 
mixture was stirred at room temperature overnight. The 
reaction mixture was then washed with brine and dried over 
NagSO^. The solvent was evaporated m vacuo and the residue 
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was chromatographed on silica gel using hexane/ether (10:1) 
as the solvent. Chromatography gave 1.07 g (4.1 ramol, 46%) 
of 1^ as a mixture of diastereomers. NMR (CDClg) 1.22 (t, 
3 H, J = 7 Hz), 1.45 (dd, 3 H), 3.62 (m, 2 H), 3.99 (s, 3 H), 
5.10 (m, 1 H), 6.52 (d, 1 H, J = 5 Hz), 7.10-8.22 (m, 4 H). 
IR (film) cm"^ 1725. High resolution mass spectrum for 
^12%2^^3 (loss of OCHgCHg) requires 218.08172; measured 
218.08130. 
Preparation of Methyl 2-(1'-t-butyldimethylsilyloxy) 
Cyanomethyl Benzoate {11) 
To a solution of 1.9 g (10 mmol) of ^  and 1.8 g (12 
mmol) of t-butyldimethylsilyl chloride in 20 mL of aceto-
nitrile was added 0.75 g (11 mmol) of imidazole. The 
solution was stirred overnight at room temperature. The 
reaction mixture was poured into 75 mL of pentane and was 
then washed with water and dried over Na2S0^. The solvent 
was evaporated and chromatography of the residue gave 1.42 g 
(4.7 mmol, 39%) of n. NMR (CDCI3) 0.15 (s, 3 H), 0.25 (s, 
3 H), 0.93 (s, 9 H), 3.90 (s, 3 H), 6.50 (s, 1 H), 7.10-8.10 
(m, 4 H). IR (film) cm~^ 1720. 
Preparation of 3,4,4a,10a-Tetrahydro-5-cyano-5-(2'-methyl-
1',3'-dioxapentyl)-3-methyl-l(2H),10-anthracenedione (7^ 
On a 4.07 mmol scale, compound 7£ was reacted with 5-
methyl cyclohexenone using the conditions for thiophenyl 
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phthalide annelations. Chromatography provided 46% of 72 
(mp 165.5-166.5 °C). NMR (CDCI3) 1.00 (d, 3 H, J = 6 Hz), 
1.27 (t, 3 H, J = 7 Hz), 1.60 (d, 3 H, J = 5 Hz), 1.90-
3.40 (m, 7 H), 3.62 (q, 2 H, J = 7 Hz), 5.23 (q, 1 H, J = 
5 Hz), 7.20-8.10 (m, 4 H). IR (CHCI3) cm"^ 1600. Anal 
calcd for C2qH22NO^: C, 70.36; H, 6.79; N, 4.10. Found 
C, 70.16; H, 6.88; N, 4.09. 
Preparation of 3,4,4a,10-Tetrahydro-5-cyano-5-t-
butyldimethylsilyloxy-3-methyl-l(2H), 10-anthracenedione (^) 
On a 4.66 ramol scale, compound 71 was reacted with 5-
methyl cyclohexenone using the conditions for thiophenyl 
phthalide annelations. Chromatography afforded 21% of 73 
(mp 182-183 °C). NMR (CDCI3) 0.37 (s, 6 H), 1.00 (s, 9 H), 
1.05 (d, 3 H), 1.85-3.15 (m, 7 H), 7.20-8.00 (m, 4 H). IR 
(CHCI3) cm"^ 1600. Anal calcd for C22H29N02Si: C, 68.89; 
H, 7.62; N, 3.65; Si, 7.32. Found C, 69.20; H, 7.67; N, 
3.54; Si, 7.44. 
Preparation of 3,4,4a,10a-Tetrahydro-9-methoxy-5,5-bis-
thiophenyl-l(2H),10-anthracenedione (7^) 
On a 5 mmol scale, methyl 2-bis-thiophenylmethyl-6-
methoxy benzoate (71) was reacted with 5-methyl cyclo­
hexenone using the conditions for thiophenyl phthalide 
annelations. Chromatography provided 37% of ^  (mp 172-
173 °C). NMR (CDCI3) 0.75 (d, 3 H, J = 6 Hz), 1.70-3.60 
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(m, 7 H), 3.95 (s, 3 H), 6.70-7.30 (m, 13 H). IR (CHCI3) 
cin~^ 1590. High resolution mass spectrum for ^22^29^3^ 
(loss of CgHgS) requires 364.11333; measured 364.11250. 
Preparation of Ethyl 2-Cyanomethyl-6-phenylsulfonyl-
oxy Benzoate (7^) 
To a solution of 16.0 g (50 mmol) of 7^ in 75 mL of 
CCl^ was added 9.1 g (55 mmol) of NBS and a few crystals 
of benzoyl peroxide. The mixture was refluxed overnight. 
After cooling to room temperature, the mixture was filtered 
and the solvent was evaporated m vacuo. The crude 
benzylic bromide was then dissolved in 40 mL of 95% EtOH 
and a solution of 2.94 g (60 mmol) of NaCN in 40 mL of 
water was added. The mixture was refluxed for 6 hours. 
The EtOH was evaporated vacuo and the aqueous solution 
was extracted with methylene chloride. The organic extract 
was dried over NagSO^, filtered and concentrated vacuo. 
Chromatography of the residue on silica gel using hexane/-
ether (1:1) as the solvent provided 2.1 g (6.1 mmol, 12%) 
of 79 (mp 51-52 °C). NMR (CDCI3) 1.33 (t, 3 H, J = 6 Hz), 
3.87 (s, 2 H), 4.27 (q, 2 H, J = 6 Hz), 6.90-7.90 (m, 8 H). 
IR (CHClg) 2250, 1730. High resolution mass spectrum for 
C17H15NO5S required 345.06710; measured 345.06758. 
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Preparation of 3,4-Dihydro-5,lO-dimethoxy-3-
trimethylsilyl-l(2H)-anthracenone (^) 
To a solution of 1.8 g (6.03 mmol) of ^  in 120 mL 
of acetone was added 2.04 mL (21,6 mmol) of dimethyl 
sulfate and 3.3 g (24 mmol) of potassium carbonate. The 
mixture was refluxed for 16 hours. On cooling to room 
temperature, the solution was filtered and solvent was 
evaporated in vacuo. Chromatography of the residue on 
silica gel using hexane/ether (10:1) as the solvent gave 
1.8 g (5.5 mmol, 91%) of ^  (mp 98-100 °C). NMR (CDCI3) 
0.10 (s, 9 H), 2.20-3.60 (m, 5 H), 3.89 (s, 3 H), 4.00 
(s, 3 H), 7.20-8.40 (m, 4 H). IR (CHCI3) cm"^ 1625. 
Preparation of l-Hydroxy-5,10-dimethoxy Anthracene (^) 
To a solution of 0.16 g (0.5 mmol) of ^  was added 
0.09 g (0.5 mmol) of NBS and a crystal of benzoyl peroxide. 
The mixture was refluxed for 1 hour. After cooling 
to room temperature, the mixture was filtered and the 
solvent was evaporated vacuo. The residue was 
chromatographed on silica gel using hexane/ether (3:1) 
as the solvent to afford 0.09 g (0.37 mmol, 74%) of 
NMR (CDCI3) 4.00 (s, 3 H), 4.03 (s, 3 H), 6.70-8.30 (m, 
7 H), 9.75 (s, 1 H). IR (Nujol) cm"^ 3340, 1630. High 
resolution mass spectrum for requires 254.0943; 
measured 254.09427. 
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Preparation of l-Hydroxy-5,10-anthracenedione (^) 
To a solution of 0.13 g (0.5 mmol) of M in 3 mL of 
glacial acetic acid was added 0.5 mL of concentrated 
nitric acid. The solution was stirred for 10 minutes 
at room temperature and then was diluted with water. The 
mixture was extracted with methylene chloride and the 
organic solution was dried over NagSO^ and then evaporated 
in vacuo to give a red solid. The product was recrystallized 
from EtOH to give fine orange needles of ^  (mp 185-187 °C, 
lit. (84) 188-189 °C). NMR (CDCI3) 6.00-7.25 (m, 7 H), 
12.50 (s, 1 H). IR (Nujol) cm"^ 1665, 1630, 1580. 
Preparation of 3,4-Dihydro-5,lO-dimethoxy-3-trimethysilyl-
1-trimethylsilyloxy Anthracene (^) 
To a 1 M THF solution of LDA (10 mmol) at -78 °C under 
N2 was added dropwise a 1 M THF solution of 3.28 g (10 
mmol) of After the solution was stirred for 20 minutes 
at -78 °C, a 1 M THF solution of 1.9 mL (15 mmol) of tri-
methylsilyl chloride and 2.1 mL (15 mmol) of triethyl 
amine was added dropwise. The solution was allowed to warm 
to 0 °C and was stirred at that temperature for 1 hour. 
The reaction mixture was poured into 150 mL of pentane. 
The solution was washed with cold 0.5 N HGl and then brine. 
The organic phase was dried over Na2S0^, filtered and 
evaporated under reduced pressure to give a quantitative 
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yield of 8^ as a viscous orange oil. NMR (CDClg) -0.08 
(s, 9 H), 0.22 (s, 9 H), 3.04 (d, 2 H, J = 6 Hz), 3.75 
(s, 3 H), 3.79 (s, 3 H), 5.36 (d, 1 H, J = 6 Hz), 7.12-
8.10 (m, 4 H). IR (film) cm"^ 1620. 
Preparation of l-Hydroxy-5,lO-dimethoxy-3-trimethyl-
silyl Anthracene (8^) 
To a solution of 1.6 g (4.0 mmol) of in 10 mL of 
methylene chloride at -60 °C was added 4.0 mL of a 1 M 
methylene chloride solution of phenylsulfenyl chloride. 
After the addition was complete, the solution was 
stirred at room temperature for 40 minutes' The reaction 
mixture was cooled to -20 °C and 0.81 g (4.0 mmol) of 85% 
MCPBA was added rapidly. The solution was stirred for 1% 
hours at -20 °C and was then washed with saturated sodium 
bicarbonate. The organic solution was washed with 
brine, dried over Na2S0^ and evaporated m vacuo. 
Chromatography of the residue on silica gel using 
hexane/ether (10:1) as the solvent provided 0.74 g (2.3 
mmol, 57%) of ^  (mp 138-139 °C). NMR (CDCI3) 0.40 (s, 9 
H), 4.16 (s, 6 H), 7.10-8.60 (m, 6 H), 9.90 (s, 1 H). IR 
(Nujol) cm"^ 3320, 1615. High resolution mass spectrum for 
^19^22^3^^ requires 326.133829; measured 326.13313. 
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Preparation of 1,5,lO-Trimethoxy-3-trimethylsilyl 
Anthracene (^) 
To a solution of 0.73 g (2.23 mmol) of 8^ in 40 mL of 
acetone was added 0.76 mL (8.03 mmol) of dimethyl sulfate 
and 1.23 g (8.92 mmol) of potassium carbonate. The 
mixture was refluxed for 23 hours. After cooling to room 
temperature, the mixture was filtered and concentrated in 
vacuo. The residue was chromatographed on silica gel using 
hexane/ether (10:1) as the solvent. Chromatography 
provided 0.74 g (2.19 mmol, 98%) of ^  (mp 93-94 °C). NMR 
(CDCI3) 0.40 (s, 9 H), 3.98 (s, 3 H), 4.05 (s, 6 H), 6.80-
8.45 (m, 6 H). IR (CHCI3) cm"^ 3000, 2960, 1600. High 
resolution mass spectrum for C^gHg^O^Si requires 340.14948; 
measured 340.14919. 
Preparation of £-Toluenesulfonyl-3,4-dihydro-5,10-
dimethoxy-3-trimethy1s ily1-1(2H)-anthracenone-2-
carboxamide (8^) 
A solution of 4.0 g (10 mmol) of ^  in 3 mL of Et^O 
was added dropwise to 1.55 mL (10 mmol) of g-toluenesulfonyl 
isocyanate. After the solution had stirred for 45 minutes 
at room temperature, the solvent was removed using an 
aspirator and 8 mL of MeOH was added. After stirring for 
30 minutes at room temperature, the solution was con­
centrated. Recrystallization from hexane/ether gave 3.05 g 
(5.8 mmol, 58%) of NMR (CDCI3) -0.27 (s, 9 H) , 2.43 
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(s, 3 H), 2.50-3.50 (m, 4 H), 3.82 (s. 3 H), 4.02 (s, 3 H), 
7.25-8.15 (m, 4 H). IR (CHCI3) cm"^ 3250, 1665, 1630. 
High resolution mass spectrum for C^gH^^O^Si (loss of 
CONHSOgPhC&g) requires 328,1495; measured 328.15069. 
Preparation of £-Toluenesulfonyl-l-hydroxy-5,10-
dimethoxyanthracene-2-carboxamide (^) 
To a solution of 2.6 g (4.94 mmol) of 88e in 20 mL 
of methylene chloride was added dropwise 4.94 mL of a 1 M 
methylene chloride solution of Br2. The reaction mixture 
was stirred for 1 hour at room temperature and then concen­
trated vacuo• Chromatography on silica gel using chloro­
form as the solvent provided 1.99 g (4.42 mmol, 90%) of 
NMR (CDCI3) 2.41 (s, 3 H), 4.01 (s, 3 H), 4.17 (s, 3 H), 
7.20-8.35 (m, 6 H), 10.55 (br s, 1 H), 11.92 (s, 1 H). 
•IR (CHCI3) cm"^ 3300, 1680, 1630. 
Preparation of 3,4-Dihydro-5,lO-dimethoxy-3-methyl-
1(2H)-anthracenone (^) 
To a solution of 4.3 g (17.7 mmol) of 54 in 350 mL 
of acetone was added 5.0 mL (53 mmol) of dimethyl sulfate 
and 7.3 g (53 mmol) of potassium carbonate. The mixture 
was refluxed for 14 hours. After cooling to room temperature, 
the reaction mixture was filtered and concentrated in 
vacuo. Chromatography on silica gel using hexane/ether 
(10:1) gave 3.93 g (14.6 mmol, 82%) of 90 (mp 109-110 °C). 
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NMR (CDCI3) 1.20 (d, 3 H, J = 5 Hz), 2.20-3.50 (m, 5 H). 
3.90 (s, 3 H), 4.02 (s, 3 H), 7.40-8.45 (m, 4 H). IR 
(Nujol) cm"^ 1670. High resolution mass spectrum for 
^17^18^3 requires 270.12560; measured 270.12565. 
Preparation of 2-Carboethoxy-3,4-dihydro-5,10-dimethoxy-
3-methyl-1 (2H) -anthracenone (^) 
To a suspension of 0.61 g (25.4 mmol) of oil free NaH 
in 20 mL of THF was added 3.1 mL (25.4 mmol) of diethyl 
carbonate, followed by dropwise addition of a 1 M THF 
solution of 3.43 g (12.7 mmol) of ^ . The mixture was 
refluxed for 48 hours. After cooling to room temperature, 
the reaction mixture was diluted with water and 
neutralized with 1 N HCl. The aqueous phase was extracted 
with ethyl acetate and the combined organic phases were 
washed with brine and dried over Na2S0^. Evaporation of 
the solvent ^  vacuo, followed by chromatography on silica 
gel using hexane/ether (10:1) as the solvent afforded 3.74 g 
(10.9 mmol, 86%) of 91 as a mixture of diastereomers. NMR 
(CDCI3) 0.97 (d, 3 H, J = 6 Hz), 1.34 (m, 3 H), 2.40-3.40 
(m, 4 H), 3.90 (s, 3 H), 4.02 (s, 3 H), 4.15 (m, 2 H), 
7.25-8.40 (m, 4 H). IR (film) cm"^ 1745, 1685, 1640, 1610. 
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Preparation of 2-Carboethoxy-l-hydroxy-5,10-dimethoxy-
3-methyl Anthracene (^) 
To a suspension of 0.072 g (3 mmol) of oil free NaH 
in 8 mL of THF was added dropwise a 1 M THF solution of 
1.03 g (3 mmol) of After the solution had been 
stirred for 30 minutes at room temperature, 2.36 mL (3 mmol) 
of a 1.27 M benzene solution of phenylsulfenyl chloride was 
added. The reaction mixture was heated to 60-70 °C and 
then a 1 M THF solution of 1.34 g (6.6 mmol) of 85% MCPBA 
was added rapidly, causing the solution to reflux vigorously. 
The solution was heated enough to maintain refluxing for 15 
minutes. After the reaction mixture had cooled to room 
temperature, it was diluted with methylene chloride and 
washed with saturated sodium bicarbonate. The organic 
solution was washed with brine, dried over NagSO^ and 
evaporated ^  vacuo. The residue was chromatographed on 
silica gel using hexane/ether (15:1) as the solvent. 
Chromatography provided 0.7 g (2.1 mmol, 70%) of ^  (mp 
122-123.5 °C). NMR (CDCI3) 1.40 (t, 3 H, J = 7 Hz), 2.56 
(s, 3 H), 4.00 (s, 3 H), 4.03 (s, 3 H), 4.40 (q, 2 H, J = 
7 Hz), 7.12-8.30 (m, 5 H), 12.36 (br s, 1 H). 90 MHz G-13 
NMR (CDCI3) 14.373, 23.475, 61.583, 62.883, 64.119, 109.575, 
113.997, 122.321, 123.167, 125.443, 126.483, 126.938, 
127.198, 133.441, 147.358, 150.870, 160.169, 171.355. 
IR (CHClg) cm~^ 3290, 1710, 1640, 1615. Oxidation as above. 
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except that the temperature was maintained at 0 °C, provided 
crude sulfone ^  (IR (film) cm'^ 1730, 1680, 1620, 1360). 
Treatment of ^  with DBN in benzene provided none of the 
desired phenol 92. 
Attempted Preparation of 92 From 4-Bromo-2-carboethoxy-3,4-
dihydro-5, lO-dimethoxy-3-methyl-1(2H) -anthracenone (^) 
To a solution of 0.51 g (1.5 mmol) of 91 in 5 mL of 
CCl^ was added 0.27 g (1.5 mmol) of NBS and a few crystals 
of benzoyl peroxide. The mixture was refluxed for 8 hours. 
On cooling to room temperature, the mixture was filtered 
and the solvent was evaporated to give the crude benzylic 
bromide ^  (NMR 4.10 (d, 1 H, J = 2 Hz)). To a solution of 
the crude bromide in 5 mL of benzene was added 0.5 g (4 
mmol) of DBN. The mixture was refluxed overnight. After 
cooling to room temperature, the solution was diluted with 
water and was then washed with 1 N HCl. The organic solu­
tion was washed with brine and dried over Na2S0^. The solvent 
was evaporated ^  vacuo. NMR analysis of the crude product 
indicated that none of the desired product ^  was present. 
Attempted Preparation of ^  From 2-Carboethoxy-3,4-dihydro-5,10-
dimethoxy-3-methyl-l(2-phenylsulfinyl)-anthracenone 
To a suspension of 0.048 g (2 mmol) of oil free NaH in 
8 mL of THF was added a 1 M THF solution of 0.68 g (2 mmol) 
of 91. After the mixture had been stirred for 30 minutes 
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at room temperature, 1.57 mL (2 mmol) of a 1.27 M benzene 
solution of phenylsulfenyl chloride was added dropwise. 
Immediately after the addition was complete the solution was 
cooled to -20 °C and 0.43 g (2.1 mmol) of 85% MCPBA was 
added. The solution was stirred at -20 °C for another 
20 minutes and then it was diluted with water and washed 
with saturated sodium bicarbonate. The organic phase was 
washed with brine, dried over NagSO^ and evaporated in 
vacuo to give the crude sulfoxide ^  (IR (film) cm~^ 1740, 
1680, 1640, 1615, 1060). The crude sulfoxide was refluxed 
overnight in both toluene and xylene, but none of the 
desired phenol ^  was obtained. 
Preparation of 2-Carboethoxy-3,4-dihydro-l,5,10-
trimethoxy-3-methyl Anthracene (9^ 
To a solution of 0.58 g (1.7 mmol) of 9^ in 30 ml, of 
acetone was added 0.25 mL (2.6 mmol) of dimethyl sulfate 
and 0.36 g (2.6 mmol) of potassium carbonate. The mixture 
was refluxed for 13 hours. After cooling to room temperature, 
the mixture was filtered and the solvent was evaporated in 
vacuo. Chromatography on silica gel using hexane/ether 
(10:1) as the solvent provided 0.69 g (1.7 mmol, 100%) of 
NMR (CDCI3) 1.40 (t, 3 H, J = 7 Hz), 2.80-3.30 (m, 
3 H), 3.75 (s, 3 H), 3.90 (s, 6 H), 4.35 (q, 2 H, J = 7 Hz), 
7.25-8.40 (m, 4 H). IR (film) cm"^ 1710, 1690, 1615. 
88 
Preparation of 2-Carboethoxy-l, 5, lO-triinethoxy-3-
methyl Anthracene (^) from ^  
To a solution of 0.71 g (2 mmol) of 94 in 6 mL of 
benzene was added 0.5 g (2.2 mmol) of DDQ. The mixture was 
refluxed for 6 hours. After cooling to room temperature, 
the mixture was filtered and the solvent was evaporated 
in vacuo. Chromatography on silica gel using hexane/ether 
(10:1) as the solvent gave 0.23 g (0.65 mmol, 33%) of ^  
(mp 93-94 °C). NMR (CDCI3) 1.40 (t, 3 H, J = 7 Hz), 2.50 
(s, 3 H), 4.00 (s, 6 H), 4.03 (s, 3 H), 4.45 (q, 2 H, J = 
7 Hz), 6.95-8.50 (m, 5 H). 90 MHz C-13 NMR (CDCI3) 14.308, 
15.608, 19.767, 61.128, 62.753, 63.598, 63.794, 72.312, 
118.419, 122.061, 122.906, 123.167, 125.182, 125.378, 
125.768, 125.898, 126.093, 128.629, 128.824, 131.230, 
168.168. IR (CHCI3) cm"l 1715, 1620. 
Preparation of ^  from ^  
To a solution of 2.03 g (5.97 mmol) of ^  in 20 mL of 
acetone was added 0.85 mL (9 mmol) of dimethyl sulfate and 
1.24 g (9 mmol) of potassium carbonate. The mixture was 
refluxed for 14 hours. After cooling to room temperature, 
the reaction mixture was filtered and the solvent was 
evaporated ^  vacuo. Chromatography on silica gel using 
hexane/ether (15:1) as the solvent afforded 1.93 g 
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(5.5 mmol, 91%) of This material was identical to 
the product prepared by DDQ oxidation of 
Preparation of Methyl 2-(2'-Carboethoxy-3'-methoxy 
phenyl) Acetate (10^) 
To a 1 M THF solution of 60 mmol of LDA at -78 °C 
under Ng was added dropwise a 1 M THF mixture of 3.88 g 
(20 mmol) of M and 3.4 mL (40 mmol) of dimethyl carbonate. 
After the addition was complete, the reaction mixture was 
allowed to warm to room temperature and was stirred for 
3% hours. The solution was then diluted with water and 
neutralized with dilute HCl. The aqueous phase was 
extracted with methylene chloride. The organic extracts 
were combined and washed with brine, dried over Na2S0^ and 
concentrated ^  vacuo. Chromatography on silica gel using 
hexane/ether (10:1) as the solvent provided 4.04 g (16 mmol, 
80%) of NMR (CDCI3) 1.34 (t, 3 H, J = 7 Hz), 3.66 
(s, 5 H), 3.82 (s, 3 H), 4.47 (q, 2 H, J = 7 Hz), 6.80-7.45 
(m, 3 H). IR (film) cm'^ 1745, 1590. 
Attempted Preparation of Methyl 2-(2'-Hydroxymethyl-
3'-methoxy phenyl) Acetate (1^) 
To a 1 M THF solution of 1.5 mmol of LDA at -78 °C 
under Ng was added a 1 M THF solution of 5.38 g (1.5 mmol) 
of 1^. The solution was stirred for 30 minutes at -78 °C 
and then 0.114 g (3 mmol) of LiAlH^ was added. The reaction 
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mixture was allowed to warm to 0 °C and was stirred for 1 
hour. The mixture was then poured into 50 mL of 3 N HCl. 
The aqueous mixture was extracted with ether. The organic 
solution was washed with brine, dried over NagSO^ and 
concentrated ^  vacuo. Based on NMR and IR analysis of 
the crude product, none of the desired hydroxyacid was 
obtained. Only a small amount of the lactone produced 
by acid induced lactonization of the hydroxyacid was 
isolated. 
Preparation of 2-Methoxy-6-methyl Benzyl Alcohol (103) 
To a suspension of 1.14 g (30 mmol) of LiAlH^ in 60 
mL of Et20 at 0 °C was added dropwise a solution of 5.82 
g (30 mmol) of ^  in 25 mL of EtgO. After the addition 
was complete, the reaction mixture was stirred for 3 hours 
at room temperature. Excess LiAlH^ was destroyed by very 
careful addition of water at 0 °C. The reaction mixture 
was acidified with 6 N HCl and then extracted with ether. 
The organic solution was washed with brine, dried over 
Na2S0^ and evaporated vacuo. The crude product was 
Kugelrohr distilled (110 °C/4 mm) to give 3.91 g (25.7 
mmol, 86%) of ^  (mp 48.5-49.5 °C). NMR (CDCI3) 2.35 
(s, 3 H), 3.80 (s, 3 H), 4.67 (br s, 2 H)-, 6.50-7.23 (m, 
3 H). IR (CHCI3) cm"^ 3600, 3450, 1585. High resolution 
mass spectrum for C^E.^2'^2 enquires 152.08373; measured 
152.08355. 
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Preparation of 2-Methoxy-6-methyl Benzaldehyde (104) 
To a suspension of 10.7 g (49.5 imnol) of pyridinium 
chlorochromate (PCC) in 60 mL of methylene chloride was 
rapidly added a solution of 5.0 g (33 mmol) of 103. The 
mixture was stirred at room temperature for 2 hours. Ether 
was added to the reaction mixture and the solvent was 
decanted. The residue in the flask was washed twice with 
ether. The combined ether washes were filtered through 
a pad of Celite and then concentrated ^  vacuo. The crude 
product was passed through a short column of silica gel to 
give 4.66 g (31 mmol, 94%) of (mp 37-38 °C) . NMR 
(CDCI3) 2.52 (s, 3 H), 3.90 (s, 3 H), 6.67-7.45 (m, 3 H), 
10.60 (s, 1 H). IR (CHCI3) cm"^ 2780, 1680. High resolution 
mass spectrum for CgH^Q02 requires 150.06808; measured 
150.067945. 
Preparation of l,3-Dimethyl-2-(2'-methoxy phenyl) 
Imidazoline (1^) 
To a solution of 4.07 g (30 mmol) of 2-methoxybenz-
aldehyde in 40 mL of benzene was added 2.8 g (31.8 mmol) of 
N,N'-dimethyl ethylene diamine, a few crystals of 
£-toluenesulfonic acid and some 3 £ molecular sieves. The 
mixture was refluxed for 48 hours. After cooling to room 
temperature, the solvent was decanted and the reaction 
flask was rinsed once with benzene. The solvent was 
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evaporated ^  vacuo and,the residue was Kugelrohr distilled 
(105 °C/0.9 mm, lit. (85) 83 °C/0.2 mm) to provide 5.6 g 
(27 mmol, 90%) of NMR (CDCI3) 2.20 (s, 6 H) , 2.60 
(m, 2 H), 3.35 (m, 2 H), 3.78 (s, 3 H), 4.08 (s, 1 H), 
6.70-7.80 (m, 4 H). 
Attempted Preparation of 2-Methoxy-6-methyl 
Benzaldehyde (1^) from 1^ 
To a solution of 0.62 g (3 mmol) of 1^ in 20 mL of 
EtgO was added 1.36 mL (9 mmol) of N,N,N',N'-tetramethyl-
ethylene diamine (TMEDA), followed by dropwise addition 
of 4.3 mL (9 mmol) of a 2.1 M hexane solution of n-BuLi. 
After the mixture had been stirred for 7 hours at room 
temperature, 3 mL (48 mmol) of methyl iodide was added. 
The mixture was stirred for 15 minutes and then the reaction 
was quenched by addition of 50 mL of 2 N HCl. After 
stirring for 10 minutes, the solution was extracted with 
chloroform. The organic solution was washed with brine, 
dried over NaSO^ and concentrated ^  vacuo. NMR analysis 
of the crude product indicated that a trace of aldehyde 
1^ had been obtained. Over 90% of the crude product was 
assigned the structure of compound 11^. NMR (CDCl^) 2.32 
(s, 3 H), 3.88 (s, 3 H), 6.70-7.80 (m, 3 H), 10.32 (s, 1 H). 
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Preparation of 1,3-Dimethyl-2-(2 *-methoxy-6'-methyl 
phenyl) Imidazolidine (1^) 
To a solution of 0.41 g (2.7 mmol) of in 7 mL of 
benzene was added 0.35 g (4.8 mmol) of N,N'-dimethyl 
ethylene diamine, two crystals of £-toluene sulfonic acid 
and some 3 X molecular sieves. The mixture was refluxed 
for 48 hours. After cooling to room temperature, the 
solvent was decanted and the reaction flask was rinsed 
with benzene. The solvent was evaporated ^  vacuo and the 
residue was Kugelrohr distilled ('-110 °C/0.9 mm) to provide 
0.46 g (2.1 mmol, 78%) of m. NMR (CDCI3) 2.16 (s, 6 H) , 
2.48 (m, 2 H), 2.58 (a, 3 H), 3.30 (m, 2 H), 3.76 (s, 3 H), 
4.25 (s, 1 H), 6.57-7.25 (m, 3 H). 
Preparation of 2-Methoxy-6-methyl Cinnamonitrile (]J.3a) 
To a suspension of 1.03 g (43 mmol) of oil free NaH in 
50 mL of THF was added 6.55 mL (40.5 mmol) of diethyl 
cyanomethylphosphonate. After the mixture had stirred for 
1 hour at room temperature, a 1 M THF solution of 6.07 g 
(40.5 mmol) of 104 was added dropwise. The mixture was 
stirred overnight at room temperature and then it was 
diluted with water. The aqueous solution was extracted 
with ether. The organic extract was washed with brine, 
dried over Na2S0^ and evaporated ^  vacuo. The crude 
product was passed through a short column of silica gel to 
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provide 6.3 g (36.4 mmol, 90%) of 113a. NMR (CDClg) 2.30 
(s, 3 H), 3.80 (s, 3 H), 6.15 (d, 1 H, J = 17 Hz), 6.55-
7.25 (m, 3 H), 7.40 (d, 1 H, J = 17 Hz). IR (CHCI3) cm"^ 
2205, 1610, 1595. 
Preparation of Ethyl 2-Methoxy-6-methyl Cinnamate (113b) 
To a solution of 3.98 g (26.5 mmol) of 1^ in 50 mL of 
benzene was added 10.2 g (29.2 mmol) of carboethoxymethylene-
triphenylphosphorane. The solution was refluxed for 15 hours. 
After cooling to room temperature, the solvent was evaporated 
in vacuo and the residue was diluted with hexane. The 
resulting suspension was filtered and the precipitate was 
washed with hexane. The combined filtrates were con­
centrated in vacuo. The crude product was passed through 
a short column of silica gel to provide 5.81 g (26.4 mmol) 
of ^3b. NMR (CDCI3) 1.30 (t, 3 H, J = 7 Hz), 2.43 (s, 3 H) , 
3.85 (s, 3 H), 4.20 (q, 2 H, J = 7 Hz), 6.52 (d, 1 H, J = 
16 Hz), 6.60-7.30 (m, 3 H), 7.80 (d, 1 H, J = 16 Hz). IR 
(film) cm"^ 1710, 1630. High resolution mass spectrum for 
^13^16^3 220.10995; measured 220.10922. 
Preparation of l-Bromomethyl-6-metho:-y Cinnamo-
nitrile (11^) 
To a solution of 6.3 g (36.4 mmol) of in 70 mL of 
CCl^ was added 13.0 g (72.8 mmol) of NBS and a few crystals 
of benzoyl peroxide. The mixture was refluxed for 72 hours. 
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After cooling to room temperature, the reaction mixture 
was filtered and the solvent was evaporated vacuo. 
Chromatography on silica gel using hexane/ether (7:1) as 
the solvent gave 6.44 g (25.6 mmol, 70%) of (mp 
78-80 °C). NMR (CDCI3) 3.86 (s, 3 H), 4.46 (s, 2 H), 6.28 
(d, 1 H, J = 17 Hz), 6.65-7.35 (m, 3 H), 7.50 (d, 1 H, 
J = 17 Hz). IB. (CHCI3) cm"l 2230, 1620, 1600, 1580. High 
resolution mass spectrum for C^^H^gErNO requires 
250,99457; measured 250.99565. 
Preparation of Ethyl l-Bromomethyl-6-methoxy Cinnamate (HAT^ 
To a solution of 5.72 g (26 mmôl) of 11^ in 30 mL of 
CCl^ was added 9.2 g (52 mmol) of NBS and a few crystals 
of benzoyl peroxide. The mixture was refluxed for 96 hours. 
After cooling to room temperature, the reaction mixture 
was filtered and the solvent was evaporated vacuo. 
Chromatography on silica gel using hexane/ether (10:1) 
provided 3.3 g (11.1 mmol, 43%) of (mp 74-75 °C). NMR 
(CDCI3) 1.33 (t, 3 H, J = 7 Hz), 3.85 (s, 3 H), 4.24 (q, 
2 H, J = 7 Hz), 4.55 (s, 2 H), 6.63 (d, 1 H, J = 16 Hz), 
6.70-7.40 (m, 3 H), 7.82 (d, 1 H, J = 16 Hz). IR (CHCI3) 
cm'^ 1700, 1625, 1590, 1570. High resolution mass spectrum 
for C23H^2Br03 requires 298.02046; measured 298.02153. 
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Preparation of 2-.Carbomethoxymethyl-6-methoxy 
Cinnamonitrile (n.5a) 
Bis -(triphenylphosine)palladitim(II) chloride (0.02 g) 
and 0.51 g (3.72 mmol) of potassium carbonate were placed 
in a three-necked flask. The flask was evacuated and a 
balloon filled with carbon monoxide gas was attached. After 
allowing the flask to fill with carbon monoxide, 5 mL of 
THF and 1 mL of MeOH were added. AIM THF solution of 
0.89 g (3.54 mmol) of 11^ was added and the reaction 
mixture was stirred for 24 hours at room temperature. The 
mixture was filtered and concentrated m vacuo. The crude 
product was passed through a short column of silica gel to 
afford 0.67 g (2.92 mmol, 82%) of 12^. NMR (CDCI3) 3.70 
(s, 3 H), 3.86 (s, 3 H), 6.22 (d, 1 H, J = 17 Hz), 6.75-
7.40 (m, 3 H), 7.44 (d, 1 H, J = 17 Hz). IR (film) cm"^ 
2200, 1730, 1610, 1590, 1570. High resolution mass spectrum 
for C^gH^^NOg requires 231.08954; measured 231.08955. 
Preparation of Ethyl 2-Carbomethoxymethyl-6-methoxy 
Cinnamate (1]^) 
Bis-(triphenyIphosphine)palladium(II) chloride (0.06 g) 
and 1.55 g (11.2 mmol) of potassium carbonate were placed in 
a three-necked flask. The flask was evacuated and à balloon 
filled with carbon monoxide gas was attached. After allow­
ing the flask to fill with carbon monoxide, 15 mL of THF 
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and 2 mL of MeOH were added. AIM THF solution of 3.31 g 
(11.1 mmol) of was added and the mixture was stirred 
for 24 hours at room temperature. The mixture was filtered 
and concentrated vacuo. Chromatography on silica gel 
using hexane/ether (5:1) provided 2.11 g (7.6 mmol, 68%) of 
11^ (mp 46-47 °C). NMR (CDCI3) 1.32 (t, 3 H, J = 7 Hz), 
3.65 (s, 3 H), 3.73 (s, 2 H), 3.83 (s, 3 H), 4.21 (q, 2 H, 
J = 7 Hz), 6.51 (d, 1 H, J = 16 Hz), 6.80-7.38 (m, 3 H), 
7.77 (d, 1 H, J = 16 Hz). IR (film) cm"^ 1740, 1715, 1630, 
1600, 1575. High resolution mass spectrum for C^gH^gO^ 
requires 278.11543; measured 278.11591. 
Preparation of 2-Carboxymethyl-6-methoxy 
Cinnamonitrile (H^) 
A solution of 0.69 g (3 mmol) of 115a and 0.63 g (15 
mmol) of lithium hydroxide in 15 mL of MeOH was refluxed 
overnight. The MeOH was evaporated vacuo and the residue 
was dissolved in water and acidified. The aqueous 
mixture was extracted with methylene chloride. The organic 
solution was washed with brine, dried over Na2S0^ and 
evaporated vacuo to give lj^6a (mp 166-168 °C). NMR 
(CDCI3) 3.70 (s, 2 H), 3.82 (s, 3 H), 6.20 (d, 1 H, J = 
17 Hz), 6.70-7.45 (m, 3 H) , 7.42 (d, 1 H,- J = 17 Hz). IR 
(CHCI3) cm'l 3400-2300, 2220, 1710, 1615, 1600, 1575. High 
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resolution mass spectrum for C^2%iN03 requires 217.07390; 
measured 217.07334. 
Preparation of 2-Carboxymethyl-6-methoxy Cinnamic Acid (H^) 
A solution of 0.83 g (3 mmol) of ll^b and 0.42 g (10 
mmol) of lithium hydroxide in 10 mL of MeOH was refluxed 
overnight. The MeOH was evaporated ^  vacuo and the 
residue was dissolved in water and acidified. The aqueous 
solution was extracted with ethyl acetate. The organic 
extract was washed with brine, dried over NagSO^ and con­
centrated ^  vacuo to provide n.^b (mp 177-178 °C). NMR 
(CDClg/dg-acetone) 3.80 (s, 2 H), 3.90 (s, 3 H), 6.53 (d, 
1 H, J = 16 Hz), 6.80-7.50 (m, 3 H), 7.80 (d, 1 H, J = 16 
Hz). IR (Nujol) cm"l 3400-2200, 1695, 1615, 1590, 1570. 
High resolution mass spectrum for ^12^12'^5 f@9uifGS 236.06848; 
measured 236.06843. 
Preparation of Ethyl 2-Aèetoxy-6-methyl Benzoate (1^) 
One drop of concentrated HgSO^ was added to a solution 
of 1.8 g (10 mmol) of 59 in 6 mL of acetic anhydride. The 
solution was stirred overnight at room temperature. Most of 
the anhydride was evaporated m vacuo and the residue was 
diluted with ether and washed with saturated sodium 
bicarbonate. The organic solution was washed with brine, 
dried over Na^SO^ and concentrated. The residue was passed 
through a short column of silica gel to give 2.04 g 
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(9.2 mmol, 92%) of m. NMR (CDCI3) 1.33 (t, 3 H, J = 7 Hz) , 
2.27 (s, 3 H), 2.40 (s, 3 H), 4.35 (q, 2 H, J = 7 Hz), 
6.82-7.60 (m, 3 H). IR (film) cm"^ 1775, 1725, 1610. High 
resolution mass spectrum for f^Suires 222.08921; 
measured 222.08908. 
Preparation of 3-Trimethylsilyloxy-lH-2-benzopyran-
1-one (12^) 
To a solution of 0.42 mL (3 mmol) of triethyl amine 
and 0.55 mL (3 mmol) of trimethylsilyltrifluoromethyl-
sulfonate in 7 mL of Et20 at 0 °C was added 0.24 g (1.5 
mmol) of homophthalic anhydride. After the mixture had 
stirred overnight at room temperature, a two phase mixture 
had formed. The upper ethereal layer was carefully with­
drawn and evaporated to give 122a. Compound 122a rapidly 
decomposed to homophthalic anhydride on standing in the air. 
Compound 122a was stable for several hours as a solution in 
chloroform. NMR (CDCl^) 0.41 (s, 9 H), 5.56 (s, 1 H), 
7.05-8.20 (m, 4 H). IR (CHCI3) cm"^ 1735, 1650. 
Preparation of 3-Methoxy-lH-2-benzopyran-l-one (122b) 
To a suspension of 0.16 g (1.0 mmol) of homophthalic 
anhydride in 5 mL of EtgO was added an excess of diazomethane 
(36). The mixture was stirred at room temperature until 
all of the anhydride had dissolved and gas evolution had 
ceased. The solution was concentrated m vacuo to give 
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12^. NMR (CDCI3) 3.9Q (s, 3 H), 5.52 (s, 1 H), 7.10-8.15 
(m, 4 H). IR (CHClg) cm"^ 1740, 1650. This material has 
been synthesized by an alternate method (86). 
Preparation of 8-Methoxy Homophthalic Anhydride (1^) 
A solution of 1.9 g (9 mmol) of 6-methoxy homophthalic 
acid (71) in 40 mL of acetyl chloride was refluxed for 2 
hours. The acetyl chloride was evaporated under reduced 
pressure. The resulting solid was suspended in cold ether 
and filtered to give 1.56 g (8.1 mmol, 90%) of (mp 
148-149 °C). NMR (CDCI3) 3.98 (s, 3 H), 4.02 (s, 2 H), 
6.80-7.72 (m, 3 H). IR (CHCI3) cm"^ 1790, 1750, 1590. 
High resolution mass spectrum for C^ Q^HQO^ requires 192.04226; 
measured 192.04298. 
101 
_ REFERENCES 
1. Henry, D. W. In "Cancer Chemotherapy"; Sartorelli, A. C.; 
Ed.; American Chemical Society: Washington, DC, 1976; 
p 15. 
2. Brown, J. R. Prog. Med. Chem. 1978, 15, 126. 
3. Arcamore, F. In "Topics in Antibiotic Chemistry"; Sammes, 
P. G., Ed.; Halsted Press: New York, 1978; Vol. 2, 
Chapter 3. 
4. Crooke, S. T.; Reich, S. D., Eds. "Anthracyclines: 
Current Status and New Developments"; Academic Press: 
New York, 1980. 
5. Oki, T.; Yoshimoto, A. Ann. Rep. Perm. Proc. 1979, 3, 
215. 
6. Remers, W. A. "The Chemistry of Antitumor Antibiotics"; 
Wiley Interscience: Somerset, NJ, 1979; Vol. I, Chapter 2. 
7. Brockmann, H.; Bauer, K. Naturwissenschaften 1950, 37, 
492. ~ 
8. Ettlinger, L.; Gaumann, E.; Hutter, R.; Keller-Schierlan, 
W.; Kradolfer, F.; Neipp, L.; Prelog, V.; Reusser, P.; 
Zahner, H. Chem. Ber. 1959, 92, 1867. 
9. (a) DiMarco, A.; Gaetani, M.; Orezzi, B.; Scarpinato, B. 
M.; Silvestrini, R.; Soldati, M.; Dasdia, T.; Valenti, L. 
Nature 1964, 201, 706. • (b) "Rubidomycin"; Bernard, J.; 
Paul, R.; Boiron, M.; Jacquillat, CI.; Mural, R., Eds.; 
Springer-Verlag: Berlin, 1969. 
10. (a) Arcamore, P.; Franceschi, G.; Penco, S.; Selva, A. 
Tetrahedron Lett. 1969, 1007. (b) DiMarco, A.; Gaetani, 
M.; Scarpinato, B. M. Cancer Chemother. Rep. 1969, 
33. 
. Doyle, T. W.; Nettleton, D. E.; Grulich, R. E.; Balitz, 
D. M.; Johnson, D. L.; Vulcano, A. L. J. Am. Chem. Soc. 
1979, 101, 7041. • ~ ~ 
. Wiley, P. F.; MacKellar, F. A.; Caron, E. L.; Kelly, R. 
C. Tetrahedron Lett. 1968, 663. Wiley, P. F.; Johnson, 
J. H.; Houser, D. J. J. Antibiotics 1977, 30, 628. 
102 
Wiley, P. F.; Elrod, D. W.; Houser, D. J.; Johnson, J. 
H.; Pschigoda, L.; Krueger, W.; Moscowitz, A. J. Org. 
Chem. 1979, 44, 4030. 
13. Kelly, R. C.; Schletter, I.; Koert, J. M.; MacKeller, F. 
A. ; Wiley, P. F. J. Or£. Chem. 1977, 3591. 
14. Arcamore, F.; Cassinelli, G.; DiMatteo, F.; Forenza, S.; 
Ripamonti, M. C.; Rivola, G.; Vigevani, A.; Clardy, J.; 
McCabe, T. J. Chem. Soc. 1980, 102, 1462. 
15. Oki, T.; Matsuzawa, Y.; Yoshimoto, A.; Numata, K.; 
Kitamura, I.; Hori, S.; Takamatsu, A.; Umezawa, H.; 
Ishizuka, M.; Naganawa, H.; Suda, H.; Hamada, M.; 
Takeuchi, T. J. Antibiotics 1975, 28, 830. 
16. Eckardt, K.; Tresselt, D.; Tax, J. Tetrahedron 1974, 
30, 3787. Arcamore, F.; Penco, S.; Vigevani, A.; 
Redaelli, S.; Franchi, G.; DiMarco, A.; Casazza, A. M.; 
Dasdia, T.; Formelli, F.; Necco, A.; Soranzo, C. 
J. Chem. 1975, 1^, 703. 
17. Gordon, J. J.; Jackman, L. M.; Ollis, W. D.; Sutherland, 
I. 0. Tetrahedron Lett. 1960, 28. 
18. Casey, M. L.; Paulick, R. C.; Whitlock, H. W. J. Org. 
Chem. 1978, 43, 1627. Wiley, P. F.; Elrod, D. W.; 
Marshall, V."7. J. Org. Chem. 1978, 3457. 
19. Oki, T.; Shibamoto, N.; Matsuzawa, Y.; Ogasawara, T.; 
Yoshimoto, A. ; Kitamura, I.; Inui, T.; Nagawana, H.; 
Takeuchi, T.; Umezawa, H. J. Antibiotics 1977, 30, 683. 
20. Misumi, M.; Yamaki, H.; Akiyama, T.; Tanaka, N. J. 
Antibiotics 1979, 48. 
21. Pigram, W. J.; Fuller, W.; Hamilton, L. D. Nature 
New Biol. 1972, 17. 
22. Rohrl, M.; Hoppe, W. Chem. Ber. 1970, 103, 3502. 
Brockmann, H.; Brockmann, H., Jr.; Niemeyer, J. 
Tetrahedron Lett. 1968, 4719. Anguili, R.; Foresti, E.; 
Riva Di Sanseverino, L.; Isaacs, N. W. ; Kennard, 0.; 
Motherwell, W. D. S.; Wampler, D. L.; Arcamore, F. 
Nature New Biol. 1971, 234, 78. 
23. Bachur, N. R.; Gordon, S. L.; Gee, M. V.; Kon, H. 
Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 954. Bachur, 
N. R. ; Gordon! §". L. ; Gee, M. V. Cancer Res. 1978, 
38, 1745. 
103 
24. Umezawa, K.; Sawamura, M.; Matsushima, T.; Sugimara, T. 
Cancer Res. 1978, 38, 1782. 
25. Wiley, P. F.; Johnson, J. H.; Houser, D. J. J. 
Antibiotics 1977, 30, 628. 
26. Crooke, S. T.; DuVernay, V.; Galvan, L.; Prestayko, A. 
W. Mol. Pharmacol. 1978, 3^, 290. 
27. Yamaki, H.; Suzuki, H.; Nishimura, T.; Tanaka, N. 
J. Antibiotics 1978, 21, 1149. 
28. Oka, S. Sci. Rep. Res. Inst. Tohoku Univ. Ser. C 1978, 
25, 37. Kato, t1; Fujikawa, T.; Matsumoto, F.; Ota, K. 
3ah to Kagaku Ryoho 1979, 6, 355. Takamoto, S.; Ota, K. 
Can to Kagaku Ryoho 1979, F, 59. 
29. Carter, S. K. J. Natl. Cancer Inst. 1975, 1265. 
30. Folkers, K.; Liu, M.; Watanabe, T.; Porter, T. H. 
Biochem. Biophys. Res. Commun. 1977, 27, 1536. 
31. Fujimoto, S.; Ingaki, J.; Horikoshi, N.; Ogawa, M. 
Gann 1979, 70, 411. 
32. Podojil, M.; Vanek, Z.; Prikrylova, V.; Blumauerova, M. 
J. Antibiotics 1978, 31., 850. Prikrylova, V.; Podojil, 
M.; Sedmera, P.; Vokoun, J.; Vanek, Z. J. Antibiotics 
1978, 31, 855. ~ 
33. McCormick, J. R. D.; Jensen, E. R. J. Am. Chem. Soc. 
1968, 90, 7126. 
34. Kelly, T. R. Annu. Rep. Med. Chem. 1979, IÂ, 288. 
35. Kelly, T. R.; Vaya, J.; Ananthasubramanian, L. J. Am. 
Chem. Soc. 1980, 1^, 5983. 
36. Jung, M. E.; Lowe, J. A. J. Chem. Soc., Chem. Commun. 
1978, 95. ~ 
37. Gesson, J. P.; Jacquesy, J. C.; Mondon, M. Tetrahedron 
Lett. 1980, 3351. 
38. Kende, A. S.; Tsay, Y.; Mills, J. E. J. Am. Chem. Soc. 
1976, 98, 1968. " ~ 
39. Savard, J.; Brassard, P. Tetrahedron Lett. 1979, 4911. 
Grandmaison, J. L.; Brassard, P. Tetrahedron Lett. 1977, 
2047. 
104 
40. Parker, K. A.; Kallmerten, J. L. Tetrahedron Lett» 
1979, 1197. Parker, K. A.; Kallmerten, J. L. J. Am. 
Chem. Soc. 1980, 102, 5881. 
41. Rende, A. S.; Rizzi, J.; Riemer, J. Tetrahedron Lett. 
1979, 1201. 
42. Parker, K. A.; Tallman, E. A. Second Chemical Congress 
of the North American Continent; Las Vegas, NV, August 
25-29, 1980; Abstracts ORGN 19. Kende, A. S.; Rizzi, 
J. P.; Boettger, S. D. Second Chemical Congress of the 
North American Continent; Las Vegas, NV, August 25-29, 
1980; Abstracts ORGN 20. 
43. Hauser, F. M.; Rhee, R. P. J. Org. Chem. 1978, 43, 
178. ~ 
44. Broom, N. J. P.; Sammes, P. G. J. Chem. Soc., Chem. 
Commun. 1978, 162. 
45. Kraus, G. A.; Sugimoto, H. Tetrahedron Lett. 1978, 2263. 
46. Li, T.; Walsgrove, T. C. Second Chemical Congress of 
the North American Continent; Las Vegas, NV, August 
25-29, 1980; Abstracts ORGN 23. 
47. Personal communication from Dr. T. Li, Institute of 
Organic Chemistry, Syntex Research, Palo Alto, CA, 
1980. 
48. Krohn, K.; Radeloff, M. Chem. 3er. 1978, 111, 3823. 
49. Lasne, M.-C., Ripoll, J.-L. Tetrahedron Lett. 1980, 463. 
50. Ager, D. J.; Fleming, I. J. Chem. Soc., Chem. Commun. 
1978, 177. ' " 
51. Laguerre, M.; Dunogues, J.; Calas, R.; Duffaut, N. J, 
Organomet. Chem. 1975, 93, C17. 
52. Castro, C. E.; Gaughan, E. J.; Owsley, D. C. J. Org. 
Chem. 1965, 30, 587. 
53. Fringuelli, F.; Pizzo, F.; Taticchi, A.; Wenkert, E. 
Syn. Commun. 1979, 9, 391. 
54. Kraus, G. A. ; Sugimoto, H. Syn. Commun. 1977, 1_, 505, 
55. Slater, G. P.; Haskins, R. H.; Hogge, L. R. ; Nesbitt, L. 
R. Can. J. Chem. 1967, 45, 92. 
105 
56. Arcamore, F. Lloydia 1977, 45. 
57. Piskov, V. B. J. Or^. Chem., USSR 1965, 1, 1254. 
58. Bondon, D.; Pietrasanta, Y.; Pucei, B. Tetrahedron 
Lett. 1977, 821. 
59. Haefliger, W.; Petrzilka, T. Helv. Chim. Acta 1966, 49, 
1937. 
60. Trost, B. M.; Rivers, G. T.; Gold, J. M. J. Org. Chem. 
1980, 1835. 
61. Roth, B. Ph.D. Thesis, Iowa State University, Ames, Iowa, 
1980. 
62. Hauser, F. M.; Combs, D. W. J. Org. Chem. 1980, 45, 
4071. " ~ 
63. Stork, G.; Maldonado, L. J. Am. Chem. Soc. 1974, 96, 
5272. 
64. Ziegler, F. E.; Schwartz, J. A. Tetrahedron Lett. 1975, 
4643. Damon, R. E.; Schlessinger, R. H.; Blount, J. F. 
J. Org. Chem. 1976, 3772. 
65. Parker, K. A.; Kallmerten, J. J. Org. Chem. 1980, 45, 
2614. ~ ~~ 
66. Chan, T. H.; Fleming, I. Synthesis, 1979, 761. 
67. (a) Gessing, E. R. F.; Sinclair, J. A.; Vollhardt, K. 
P. C. J. Chem. Soc., Chem. Commun. 1980, 286. (b) Eaborn, 
C.; Najam, A. A.; Walton, D. R. M. J. Chem. Soc., Perkin 
Trans. I 1972, 2481. (c) Ho, T.-L.; Olah, G. A. Proc. 
Natl. Acad. Sci. USA 1978, 75, 4. (d) Felix, G.; Dunogues, 
j. ; Pisciotti, F. ; Calas, R. An<?ew. Chem. Int. Ed. Engl. 
1977, 16, 488. ~ 
68. Gschwend, H. W.; Rodriguez, H. R. Org. Reactions 1979, 
26, 1. 
69. Inaba, S.; Ojima, I.; Yoshida, K.; Nagai, M. J. Organomet. 
Chem. 1979, 164, 123. 
70. Zima, G.; Barnum, C.; Liotta, D. J. Org. Chem. 1980, 45, 
2736. " ~ 
71. Hauser, F. M.; Rhee, R. P.; Prasanna, S. Synthesis, 1980, 
72. Hauser, F. M.. ; Rhee, R. Synthesis 1977, 245. 
106 
72. Kraus, G. A.; Frazier, K. J. Org. Chem. 1980, 4262. 
73. Harris, D. H.; Roth, G. P. J. Org. Chem. 1979, 2004. 
74. Plaumann, H. P.; Keay, B. A.; Rodrigo, R. Tetrahedron 
Lett. 1979, 4921. 
75. Cowell, A.; Stille, J. K. J. Am. Chem. Soc. 1980, 102, 
4193. ~ 
76. Cheung, Y. Tetrahedron Lett. 1979, 3809. 
77. (a) Trost, B. M. ; Rivers, G. T.; Gold, J. M. J. Org. 
Chem. 1980, 1835. (b) Corey, E. J. ; TrybuXski, E. 
J.; Melvin, L. S.; Nicolaou, K. C.; Secrist, J. A. ; 
Lett. R.; Sheldrake, P. W.; Falck, J. R.; Brunelle, D. J.; 
Haslanger, M. F.; Kim, S.; Yoo, S. J. Am. Chem. Soc. 
1978, 100, 4618. (c) Nicolaou, K. C.; Seitz, S. P.; 
Sipio, W. J.; Blount, J. F. J. Am. Chem. Soc. 1979, 
101, 3884. (d) Henbest, H. B.; Î^TchoTTs, B. J. Chem. 
goc. 1959, 227. 
78. Creger, P. L. J. Chem. Soc. 1967, 2500. 
79. Brown, C.; Sargent, M. V. J. Chem. Soc. (C) 1969, 1818. 
80. Stridsberg, B.; Allenmark, S. Acta Chem, Scand. 1976, 
B30. 219. 
81. Cregge, R. ; Herrmann, J. L.; Lee, C. S.; Richman, J. E.; 
Schlessinger, R. H. Tetrahedron Lett. 1973, 2425. 
82. Read, G.; Ruiz, V. M. J. Chem. Soc. Perkin I 1973, 235. 
83. Piers, E.; Nagakura, I. Syn. Commun. 1975, 193. 
Mukherjee, S. J. Ind. Chem. Soc. 1962, 39, 347. 
84. Bloom, H.; Briggs, L. H.; Cleverley, B. J. Chem. Soc. 
1959, 178. " 
85. Fife. T. H.; Hutchins, J. E. C. J. Am. Chem. Soc. 1976, 
98, 2536. ~ 
86. Spangler, R. J.; Kim, J. H.; Cava, M. P. J. Org. Chem. 
1977, 42, 1697. " 
107 
ACKNOI^LEDGEMENTS 
I would like to thank Dr. G. A. Kraus for his guidance 
and encouragement throughout this project. The stimulating 
and challenging atmosphere he provided in his group was 
invaluable. 
I would like to express a special thanks to my parents. 
Their support, encouragement and understanding during the 
last four years helped to make everything possible. 
Finally, I want to thank Ms. Gay Grimes, who did an 
excellent job of typing this manuscript and drawing all 
of the structures. Her suggestions and assistance made 
the writing of this thesis a less difficult task. 
